{"id": "AIMed.d117.s984_AIMed.d117.s984.p0", "text": "The beta:beta activin homodimer and alpha:beta inhibin heterodimer are mutual antagonists which share a common beta subunit.", "text_with_entity_marker": "The beta:[E1]beta activin[/E1] homodimer and alpha:[E2]beta inhibin[/E2] heterodimer are mutual antagonists which share a common beta subunit.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta activin", "entity_1_idx": [[9, 21]], "entity_1_idx_in_text_with_entity_marker": [13, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta inhibin", "entity_2_idx": [[42, 54]], "entity_2_idx_in_text_with_entity_marker": [55, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s987_AIMed.d117.s987.p0", "text": "Activin type I receptors, SKR1 and SKR2, were first cloned from well differentiated human hepatoma cells (HepG2).", "text_with_entity_marker": "Activin type I receptors, [E1]SKR1[/E1] and [E2]SKR2[/E2], were first cloned from well differentiated human hepatoma cells (HepG2).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SKR1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SKR2", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p0", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:[E1]beta activin[/E1] binds to the [E2]activin type II receptor kinase[/E2] (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta activin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "activin type II receptor kinase", "entity_2_idx": [[49, 80]], "entity_2_idx_in_text_with_entity_marker": [62, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p1", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:[E1]beta activin[/E1] binds to the activin type II receptor kinase ([E2]ActRII[/E2]) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta activin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p2", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:[E1]beta activin[/E1] binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase [E2]SKR2[/E2] to form ActRII.beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta activin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SKR2", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p3", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:[E1]beta activin[/E1] binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form [E2]ActRII[/E2].beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta activin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p4", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:beta activin binds to the [E1]activin type II receptor kinase[/E1] ([E2]ActRII[/E2]) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "activin type II receptor kinase", "entity_1_idx": [[49, 80]], "entity_1_idx_in_text_with_entity_marker": [53, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p5", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:beta activin binds to the [E1]activin type II receptor kinase[/E1] (ActRII) which induces activin binding to the type I receptor kinase [E2]SKR2[/E2] to form ActRII.beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "activin type II receptor kinase", "entity_1_idx": [[49, 80]], "entity_1_idx_in_text_with_entity_marker": [53, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SKR2", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p6", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:beta activin binds to the [E1]activin type II receptor kinase[/E1] (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form [E2]ActRII[/E2].beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "activin type II receptor kinase", "entity_1_idx": [[49, 80]], "entity_1_idx_in_text_with_entity_marker": [53, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p7", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:beta activin binds to the activin type II receptor kinase ([E1]ActRII[/E1]) which induces activin binding to the type I receptor kinase [E2]SKR2[/E2] to form ActRII.beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActRII", "entity_1_idx": [[82, 88]], "entity_1_idx_in_text_with_entity_marker": [86, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SKR2", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p8", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:beta activin binds to the activin type II receptor kinase ([E1]ActRII[/E1]) which induces activin binding to the type I receptor kinase SKR2 to form [E2]ActRII[/E2].beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActRII", "entity_1_idx": [[82, 88]], "entity_1_idx_in_text_with_entity_marker": [86, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p9", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase [E1]SKR2[/E1] to form [E2]ActRII[/E2].beta:beta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SKR2", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s990_AIMed.d117.s990.p0", "text": "SKR2 complexes in which an activin beta chain occupies each receptor subunit.", "text_with_entity_marker": "[E1]SKR2[/E1] complexes in which an [E2]activin beta[/E2] chain occupies each receptor subunit.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SKR2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "activin beta", "entity_2_idx": [[27, 39]], "entity_2_idx_in_text_with_entity_marker": [40, 52], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p0", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "[E1]Inhibin[/E1] also binds to [E2]ActRII[/E2] through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Inhibin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[22, 28]], "entity_2_idx_in_text_with_entity_marker": [35, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p1", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "[E1]Inhibin[/E1] also binds to ActRII through its beta subunit, competes with the binding of activin to [E2]ActRII[/E2], but fails to form the ActRII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Inhibin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[95, 101]], "entity_2_idx_in_text_with_entity_marker": [108, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p2", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "[E1]Inhibin[/E1] also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the [E2]ActRII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Inhibin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[125, 131]], "entity_2_idx_in_text_with_entity_marker": [138, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p3", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "Inhibin also binds to [E1]ActRII[/E1] through its beta subunit, competes with the binding of activin to [E2]ActRII[/E2], but fails to form the ActRII.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActRII", "entity_1_idx": [[22, 28]], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[95, 101]], "entity_2_idx_in_text_with_entity_marker": [108, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p4", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "Inhibin also binds to [E1]ActRII[/E1] through its beta subunit, competes with the binding of activin to ActRII, but fails to form the [E2]ActRII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActRII", "entity_1_idx": [[22, 28]], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[125, 131]], "entity_2_idx_in_text_with_entity_marker": [138, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p5", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to [E1]ActRII[/E1], but fails to form the [E2]ActRII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActRII", "entity_1_idx": [[95, 101]], "entity_1_idx_in_text_with_entity_marker": [99, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[125, 131]], "entity_2_idx_in_text_with_entity_marker": [138, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s671_AIMed.d79.s671.p0", "text": "The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.", "text_with_entity_marker": "The [E1]retinoblastoma[/E1] protein binds to [E2]RIZ[/E2], a zinc-finger protein that shares an epitope with the adenovirus E1A protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "retinoblastoma", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RIZ", "entity_2_idx": [[36, 39]], "entity_2_idx_in_text_with_entity_marker": [49, 52], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s671_AIMed.d79.s671.p1", "text": "The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.", "text_with_entity_marker": "The [E1]retinoblastoma[/E1] protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus [E2]E1A[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "retinoblastoma", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s671_AIMed.d79.s671.p2", "text": "The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.", "text_with_entity_marker": "The retinoblastoma protein binds to [E1]RIZ[/E1], a zinc-finger protein that shares an epitope with the adenovirus [E2]E1A[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIZ", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s672_AIMed.d79.s672.p0", "text": "The retinoblastoma protein (Rb) is a target of viral oncoproteins.", "text_with_entity_marker": "The [E1]retinoblastoma protein[/E1] ([E2]Rb[/E2]) is a target of viral oncoproteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "retinoblastoma protein", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[28, 30]], "entity_2_idx_in_text_with_entity_marker": [41, 43], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s676_AIMed.d79.s676.p0", "text": "It contains an Rb-binding motif that shares an antigenic epitope with the C terminus of E1A.", "text_with_entity_marker": "It contains an [E1]Rb[/E1]-binding motif that shares an antigenic epitope with the C terminus of [E2]E1A[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[15, 17]], "entity_1_idx_in_text_with_entity_marker": [19, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[88, 91]], "entity_2_idx_in_text_with_entity_marker": [101, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s677_AIMed.d79.s677.p0", "text": "A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor.", "text_with_entity_marker": "A domain is conserved between [E1]RIZ[/E1] and the [E2]PRDI-BF1[/E2]/Blimp-1 differentiation factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIZ", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PRDI-BF1", "entity_2_idx": [[42, 50]], "entity_2_idx_in_text_with_entity_marker": [55, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s677_AIMed.d79.s677.p1", "text": "A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor.", "text_with_entity_marker": "A domain is conserved between [E1]RIZ[/E1] and the PRDI-BF1/[E2]Blimp-1[/E2] differentiation factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIZ", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Blimp-1", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s677_AIMed.d79.s677.p2", "text": "A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor.", "text_with_entity_marker": "A domain is conserved between RIZ and the [E1]PRDI-BF1[/E1]/[E2]Blimp-1[/E2] differentiation factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRDI-BF1", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Blimp-1", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s681_AIMed.d79.s681.p0", "text": "While the function of RIZ is not yet clear, its structure and pattern of expression suggest a role for RIZ in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.", "text_with_entity_marker": "While the function of [E1]RIZ[/E1] is not yet clear, its structure and pattern of expression suggest a role for [E2]RIZ[/E2] in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIZ", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RIZ", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s695_AIMed.d82.s695.p0", "text": "Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.", "text_with_entity_marker": "Identification of an 11-kDa [E1]FKBP12[/E1]-rapamycin-binding domain within the 289-kDa [E2]FKBP12-rapamycin-associated protein[/E2] and characterization of a critical serine residue.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FKBP12", "entity_1_idx": [[28, 34]], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FKBP12-rapamycin-associated protein", "entity_2_idx": [[79, 114]], "entity_2_idx_in_text_with_entity_marker": [92, 127], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s697_AIMed.d82.s697.p0", "text": "Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].", "text_with_entity_marker": "Previously, a mammalian protein that directly associates with [E1]FKBP12[/E1]-rapamycin has been identified and its encoding gene has been cloned from both human (designated [E2]FRAP[/E2]) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FKBP12", "entity_1_idx": [[62, 68]], "entity_1_idx_in_text_with_entity_marker": [66, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FRAP", "entity_2_idx": [[165, 169]], "entity_2_idx_in_text_with_entity_marker": [178, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s697_AIMed.d82.s697.p1", "text": "Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].", "text_with_entity_marker": "Previously, a mammalian protein that directly associates with [E1]FKBP12[/E1]-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated [E2]RAFT[/E2]) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FKBP12", "entity_1_idx": [[62, 68]], "entity_1_idx_in_text_with_entity_marker": [66, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RAFT", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s697_AIMed.d82.s697.p2", "text": "Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].", "text_with_entity_marker": "Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated [E1]FRAP[/E1]) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated [E2]RAFT[/E2]) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FRAP", "entity_1_idx": [[165, 169]], "entity_1_idx_in_text_with_entity_marker": [169, 173], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RAFT", "entity_2_idx": [[324, 328]], "entity_2_idx_in_text_with_entity_marker": [337, 341], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s699_AIMed.d82.s699.p0", "text": "Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa FKBP12-rapamycin-binding domain within FRAP.", "text_with_entity_marker": "Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa [E1]FKBP12[/E1]-rapamycin-binding domain within [E2]FRAP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FKBP12", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FRAP", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p0", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of [E1]hTAFII18[/E1], [E2]hTAFII20[/E2] and hTAFII28: three subunits of the human transcription factor TFIID.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[42, 50]], "entity_2_idx_in_text_with_entity_marker": [55, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p1", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of [E1]hTAFII18[/E1], hTAFII20 and [E2]hTAFII28[/E2]: three subunits of the human transcription factor TFIID.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p2", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of [E1]hTAFII18[/E1], hTAFII20 and hTAFII28: three subunits of the human transcription factor [E2]TFIID[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p3", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of hTAFII18, [E1]hTAFII20[/E1] and [E2]hTAFII28[/E2]: three subunits of the human transcription factor TFIID.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p4", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of hTAFII18, [E1]hTAFII20[/E1] and hTAFII28: three subunits of the human transcription factor [E2]TFIID[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p5", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of hTAFII18, hTAFII20 and [E1]hTAFII28[/E1]: three subunits of the human transcription factor [E2]TFIID[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[55, 63]], "entity_1_idx_in_text_with_entity_marker": [59, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p0", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] ([E2]TBP[/E2])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[72, 75]], "entity_2_idx_in_text_with_entity_marker": [85, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p1", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell [E2]TFIID[/E2] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p2", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E2]hTAFII28[/E2], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p3", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E2]hTAFII20[/E2] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[152, 160]], "entity_2_idx_in_text_with_entity_marker": [165, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p4", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E2]hTAFII18[/E2]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[165, 173]], "entity_2_idx_in_text_with_entity_marker": [178, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p5", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E2]hTAFII28[/E2] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p6", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p7", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p8", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p9", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p10", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p11", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p12", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p13", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p14", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p15", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p16", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [[E1]TATA-binding protein[/E1] (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TATA-binding protein", "entity_1_idx": [[50, 70]], "entity_1_idx_in_text_with_entity_marker": [54, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p17", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell [E2]TFIID[/E2] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p18", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes [E2]hTAFII28[/E2], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p19", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E2]hTAFII20[/E2] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[152, 160]], "entity_2_idx_in_text_with_entity_marker": [165, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p20", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E2]hTAFII18[/E2]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[165, 173]], "entity_2_idx_in_text_with_entity_marker": [178, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p21", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E2]hTAFII28[/E2] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p22", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p23", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p24", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p25", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p26", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p27", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p28", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p29", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p30", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p31", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p32", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein ([E1]TBP[/E1])-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p33", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes [E2]hTAFII28[/E2], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p34", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, [E2]hTAFII20[/E2] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[152, 160]], "entity_2_idx_in_text_with_entity_marker": [165, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p35", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and [E2]hTAFII18[/E2]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[165, 173]], "entity_2_idx_in_text_with_entity_marker": [178, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p36", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. [E2]hTAFII28[/E2] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p37", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p38", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p39", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p40", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p41", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p42", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p43", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p44", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p45", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p46", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p47", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell [E1]TFIID[/E1] complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[126, 131]], "entity_1_idx_in_text_with_entity_marker": [130, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p48", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], [E2]hTAFII20[/E2] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[152, 160]], "entity_2_idx_in_text_with_entity_marker": [165, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p49", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and [E2]hTAFII18[/E2]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[165, 173]], "entity_2_idx_in_text_with_entity_marker": [178, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p50", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. [E2]hTAFII28[/E2] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p51", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p52", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p53", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p54", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p55", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p56", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p57", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p58", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p59", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p60", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p61", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes [E1]hTAFII28[/E1], hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p62", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and [E2]hTAFII18[/E2]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[165, 173]], "entity_2_idx_in_text_with_entity_marker": [178, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p63", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. [E2]hTAFII28[/E2] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p64", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p65", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p66", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p67", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p68", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p69", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p70", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p71", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p72", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p73", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p74", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, [E1]hTAFII20[/E1] and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p75", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. [E2]hTAFII28[/E2] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p76", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p77", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p78", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p79", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p80", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p81", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p82", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p83", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p84", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p85", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p86", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and [E1]hTAFII18[/E1]. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p87", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core [E2]hTAFII[/E2] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[194, 200]], "entity_2_idx_in_text_with_entity_marker": [207, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p88", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p89", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p90", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p91", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p92", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p93", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p94", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p95", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p96", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p97", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. [E1]hTAFII28[/E1] is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p98", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described [E2]hTFIID[/E2] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[245, 251]], "entity_2_idx_in_text_with_entity_marker": [258, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p99", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p100", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p101", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p102", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p103", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p104", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p105", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p106", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p107", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core [E1]hTAFII[/E1] present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[194, 200]], "entity_1_idx_in_text_with_entity_marker": [198, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p108", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain [E2]hTAFII30[/E2] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[289, 297]], "entity_2_idx_in_text_with_entity_marker": [302, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p109", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p110", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p111", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p112", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p113", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p114", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p115", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p116", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described [E1]hTFIID[/E1] species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[245, 251]], "entity_1_idx_in_text_with_entity_marker": [249, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p117", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] ([E2]hTFIID[/E2] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[299, 305]], "entity_2_idx_in_text_with_entity_marker": [312, 318], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p118", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] ([E2]hTFIID alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [312, 324], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p119", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] (hTFIID alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p120", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] (hTFIID alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p121", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p122", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p123", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p124", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain [E1]hTAFII30[/E1] (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII30", "entity_1_idx": [[289, 297]], "entity_1_idx_in_text_with_entity_marker": [293, 301], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p125", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1-E2]hTFIID[/E1] alpha[/E2] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [306, 312], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID[/E1] alpha", "entity_2_idx": [[299, 311]], "entity_2_idx_in_text_with_entity_marker": [306, 323], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p126", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID[/E1] alpha and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [303, 309], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p127", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID[/E1] alpha and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [303, 309], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p128", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID[/E1] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [303, 309], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p129", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID[/E1] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [303, 309], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p130", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID[/E1] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [303, 309], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p131", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID[/E1] alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[299, 305]], "entity_1_idx_in_text_with_entity_marker": [303, 309], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p132", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID alpha[/E1] and [E2]hTFIID[/E2] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID alpha", "entity_1_idx": [[299, 311]], "entity_1_idx_in_text_with_entity_marker": [303, 315], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[316, 322]], "entity_2_idx_in_text_with_entity_marker": [329, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p133", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID alpha[/E1] and [E2]hTFIID beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID alpha", "entity_1_idx": [[299, 311]], "entity_1_idx_in_text_with_entity_marker": [303, 315], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [329, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p134", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID alpha[/E1] and hTFIID beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID alpha", "entity_1_idx": [[299, 311]], "entity_1_idx_in_text_with_entity_marker": [303, 315], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p135", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID alpha[/E1] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID alpha", "entity_1_idx": [[299, 311]], "entity_1_idx_in_text_with_entity_marker": [303, 315], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p136", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID alpha[/E1] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID alpha", "entity_1_idx": [[299, 311]], "entity_1_idx_in_text_with_entity_marker": [303, 315], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p137", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 ([E1]hTFIID alpha[/E1] and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID alpha", "entity_1_idx": [[299, 311]], "entity_1_idx_in_text_with_entity_marker": [303, 315], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p138", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1-E2]hTFIID[/E1] beta[/E2] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[316, 322]], "entity_1_idx_in_text_with_entity_marker": [323, 329], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID[/E1] beta", "entity_2_idx": [[316, 327]], "entity_2_idx_in_text_with_entity_marker": [323, 339], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p139", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID[/E1] beta respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[316, 322]], "entity_1_idx_in_text_with_entity_marker": [320, 326], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p140", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID[/E1] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[316, 322]], "entity_1_idx_in_text_with_entity_marker": [320, 326], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p141", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID[/E1] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[316, 322]], "entity_1_idx_in_text_with_entity_marker": [320, 326], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p142", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID[/E1] beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID", "entity_1_idx": [[316, 322]], "entity_1_idx_in_text_with_entity_marker": [320, 326], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p143", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID beta[/E1] respectively), and is the homologue of Drosophila (d)[E2]TAFII30 beta[/E2]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID beta", "entity_1_idx": [[316, 327]], "entity_1_idx_in_text_with_entity_marker": [320, 331], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 beta", "entity_2_idx": [[381, 393]], "entity_2_idx_in_text_with_entity_marker": [394, 406], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p144", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID beta[/E1] respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID beta", "entity_1_idx": [[316, 327]], "entity_1_idx_in_text_with_entity_marker": [320, 331], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p145", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID beta[/E1] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID beta", "entity_1_idx": [[316, 327]], "entity_1_idx_in_text_with_entity_marker": [320, 331], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p146", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and [E1]hTFIID beta[/E1] respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTFIID beta", "entity_1_idx": [[316, 327]], "entity_1_idx_in_text_with_entity_marker": [320, 331], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p147", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E1]TAFII30 beta[/E1]. [E2]hTAFII18[/E2] is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TAFII30 beta", "entity_1_idx": [[381, 393]], "entity_1_idx_in_text_with_entity_marker": [385, 397], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p148", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E1]TAFII30 beta[/E1]. hTAFII18 is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TAFII30 beta", "entity_1_idx": [[381, 393]], "entity_1_idx_in_text_with_entity_marker": [385, 397], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p149", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)[E1]TAFII30 beta[/E1]. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TAFII30 beta", "entity_1_idx": [[381, 393]], "entity_1_idx_in_text_with_entity_marker": [385, 397], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p150", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E1]hTAFII18[/E1] is a novel [E2]hTAFII[/E2] which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[415, 421]], "entity_2_idx_in_text_with_entity_marker": [428, 434], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p151", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. [E1]hTAFII18[/E1] is a novel hTAFII which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s868_AIMed.d103.s868.p152", "text": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel hTAFII which shows homology to the N-terminal region of the yeast TAFIISPT3, but has no known Drosophila counterpart.", "text_with_entity_marker": "We have cloned cDNAs encoding three novel TAFIIs [TATA-binding protein (TBP)-associated factors] from the human (h) HeLa cell TFIID complexes hTAFII28, hTAFII20 and hTAFII18. hTAFII28 is a core hTAFII present in both of the previously described hTFIID species which either lack or contain hTAFII30 (hTFIID alpha and hTFIID beta respectively), and is the homologue of Drosophila (d)TAFII30 beta. hTAFII18 is a novel [E1]hTAFII[/E1] which shows homology to the N-terminal region of the yeast [E2]TAFIISPT3[/E2], but has no known Drosophila counterpart.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[415, 421]], "entity_1_idx_in_text_with_entity_marker": [419, 425], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFIISPT3", "entity_2_idx": [[481, 490]], "entity_2_idx_in_text_with_entity_marker": [494, 503], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p0", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], [E2]hTAFII18[/E2] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[25, 33]], "entity_2_idx_in_text_with_entity_marker": [38, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p1", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a [E2]TFIID[/E2] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p2", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a [E2]TFIID beta[/E2]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID beta", "entity_2_idx": [[39, 49]], "entity_2_idx_in_text_with_entity_marker": [52, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p3", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p4", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p5", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p6", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p7", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p8", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a [E2]TFIID[/E2] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p9", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a [E2]TFIID beta[/E2]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID beta", "entity_2_idx": [[39, 49]], "entity_2_idx_in_text_with_entity_marker": [52, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p10", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p11", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p12", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p13", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p14", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p15", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1-E2]TFIID[/E1] beta[/E2]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID[/E1] beta", "entity_2_idx": [[39, 49]], "entity_2_idx_in_text_with_entity_marker": [46, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p16", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p17", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p18", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p19", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p20", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p21", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p22", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p23", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p24", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p25", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p26", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p27", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p28", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p29", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p30", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. [E1]hTAFII20[/E1] is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p31", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. [E1]hTAFII20[/E1] is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p32", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. [E1]hTAFII20[/E1] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p33", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E1]p22[/E1], an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p22", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p34", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E1]p22[/E1], an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p22", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p35", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E1]TAFII30 alpha[/E1] ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TAFII30 alpha", "entity_1_idx": [[135, 148]], "entity_1_idx_in_text_with_entity_marker": [139, 152], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p0", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that [E1]hTAFII28[/E1] interacts with [E2]hTAFII18[/E2] both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII28", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [50, 58], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p1", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that [E1]hTAFII28[/E1] interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, [E2]hTAFII28[/E2] also interacts directly with TBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[122, 130]], "entity_2_idx_in_text_with_entity_marker": [135, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p2", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that [E1]hTAFII28[/E1] interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with [E2]TBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p3", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that hTAFII28 interacts with [E1]hTAFII18[/E1] both in vitro and intracellularly; in contrast to its Drosophila homologue, [E2]hTAFII28[/E2] also interacts directly with TBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[122, 130]], "entity_2_idx_in_text_with_entity_marker": [135, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p4", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that hTAFII28 interacts with [E1]hTAFII18[/E1] both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with [E2]TBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p5", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, [E1]hTAFII28[/E1] also interacts directly with [E2]TBP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII28", "entity_1_idx": [[122, 130]], "entity_1_idx_in_text_with_entity_marker": [126, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p0", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and [E2]hTAFII18[/E2] bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[41, 49]], "entity_2_idx_in_text_with_entity_marker": [54, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p1", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and hTAFII18 bind to distinct domains of [E2]hTAFII28[/E2]. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p2", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and hTAFII18 bind to distinct domains of hTAFII28. [E2]hTAFII18[/E2] also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p3", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with [E2]TBP[/E2], but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p4", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with [E2]hTAFII28[/E2] and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p5", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p6", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and [E1]hTAFII18[/E1] bind to distinct domains of [E2]hTAFII28[/E2]. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p7", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and [E1]hTAFII18[/E1] bind to distinct domains of hTAFII28. [E2]hTAFII18[/E2] also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p8", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and [E1]hTAFII18[/E1] bind to distinct domains of hTAFII28. hTAFII18 also interacts with [E2]TBP[/E2], but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p9", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and [E1]hTAFII18[/E1] bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with [E2]hTAFII28[/E2] and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p10", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and [E1]hTAFII18[/E1] bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII18", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p11", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of [E1]hTAFII28[/E1]. [E2]hTAFII18[/E2] also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p12", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of [E1]hTAFII28[/E1]. hTAFII18 also interacts with [E2]TBP[/E2], but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p13", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of [E1]hTAFII28[/E1]. hTAFII18 also interacts with TBP, but it interacts more strongly with [E2]hTAFII28[/E2] and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p14", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of [E1]hTAFII28[/E1]. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p15", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. [E1]hTAFII18[/E1] also interacts with [E2]TBP[/E2], but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p16", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. [E1]hTAFII18[/E1] also interacts with TBP, but it interacts more strongly with [E2]hTAFII28[/E2] and hTAFII30.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p17", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. [E1]hTAFII18[/E1] also interacts with TBP, but it interacts more strongly with hTAFII28 and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p18", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with [E1]TBP[/E1], but it interacts more strongly with [E2]hTAFII28[/E2] and hTAFII30.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[117, 120]], "entity_1_idx_in_text_with_entity_marker": [121, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p19", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with [E1]TBP[/E1], but it interacts more strongly with hTAFII28 and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[117, 120]], "entity_1_idx_in_text_with_entity_marker": [121, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p20", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with [E1]hTAFII28[/E1] and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[158, 166]], "entity_1_idx_in_text_with_entity_marker": [162, 170], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s873_AIMed.d103.s873.p0", "text": "The binding of hTAFII28 and hTAFII30 requires distinct domains of hTAFII18.", "text_with_entity_marker": "The binding of [E1]hTAFII28[/E1] and [E2]hTAFII30[/E2] requires distinct domains of hTAFII18.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[28, 36]], "entity_2_idx_in_text_with_entity_marker": [41, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s873_AIMed.d103.s873.p1", "text": "The binding of hTAFII28 and hTAFII30 requires distinct domains of hTAFII18.", "text_with_entity_marker": "The binding of [E1]hTAFII28[/E1] and hTAFII30 requires distinct domains of [E2]hTAFII18[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s873_AIMed.d103.s873.p2", "text": "The binding of hTAFII28 and hTAFII30 requires distinct domains of hTAFII18.", "text_with_entity_marker": "The binding of hTAFII28 and [E1]hTAFII30[/E1] requires distinct domains of [E2]hTAFII18[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII30", "entity_1_idx": [[28, 36]], "entity_1_idx_in_text_with_entity_marker": [32, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p0", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, [E1]hTAFII20[/E1] interacts directly with [E2]TBP[/E2]; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p1", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, [E1]hTAFII20[/E1] interacts directly with TBP; however, additional interactions between [E2]hTAFII20[/E2] and hTAFII28 or hTAFII30 were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p2", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, [E1]hTAFII20[/E1] interacts directly with TBP; however, additional interactions between hTAFII20 and [E2]hTAFII28[/E2] or hTAFII30 were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p3", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, [E1]hTAFII20[/E1] interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or [E2]hTAFII30[/E2] were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII20", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p4", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with [E1]TBP[/E1]; however, additional interactions between [E2]hTAFII20[/E2] and hTAFII28 or hTAFII30 were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[86, 89]], "entity_1_idx_in_text_with_entity_marker": [90, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p5", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with [E1]TBP[/E1]; however, additional interactions between hTAFII20 and [E2]hTAFII28[/E2] or hTAFII30 were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[86, 89]], "entity_1_idx_in_text_with_entity_marker": [90, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p6", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with [E1]TBP[/E1]; however, additional interactions between hTAFII20 and hTAFII28 or [E2]hTAFII30[/E2] were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TBP", "entity_1_idx": [[86, 89]], "entity_1_idx_in_text_with_entity_marker": [90, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p7", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between [E1]hTAFII20[/E1] and [E2]hTAFII28[/E2] or hTAFII30 were detected.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p8", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between [E1]hTAFII20[/E1] and hTAFII28 or [E2]hTAFII30[/E2] were detected.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p9", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and [E1]hTAFII28[/E1] or [E2]hTAFII30[/E2] were detected.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hTAFII28", "entity_1_idx": [[145, 153]], "entity_1_idx_in_text_with_entity_marker": [149, 157], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s875_AIMed.d103.s875.p0", "text": "These results reveal differences not only in subunit composition, but also in the organization of dTFIID and hTFIID complexes.", "text_with_entity_marker": "These results reveal differences not only in subunit composition, but also in the organization of [E1]dTFIID[/E1] and [E2]hTFIID[/E2] complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dTFIID", "entity_1_idx": [[98, 104]], "entity_1_idx_in_text_with_entity_marker": [102, 108], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTFIID", "entity_2_idx": [[109, 115]], "entity_2_idx_in_text_with_entity_marker": [122, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1309_AIMed.d154.s1309.p0", "text": "We have cloned and characterized human acidic (alpha 1-) syntrophin and a second isoform of human basic (beta 2-) syntrophin.", "text_with_entity_marker": "We have cloned and characterized human [E1]acidic (alpha 1-) syntrophin[/E1] and a second isoform of human [E2]basic (beta 2-) syntrophin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acidic (alpha 1-) syntrophin", "entity_1_idx": [[39, 67]], "entity_1_idx_in_text_with_entity_marker": [43, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "basic (beta 2-) syntrophin", "entity_2_idx": [[98, 124]], "entity_2_idx_in_text_with_entity_marker": [111, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1311_AIMed.d154.s1311.p0", "text": "The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.", "text_with_entity_marker": "The deduced amino acid sequences of human alpha 1- and [E1]beta 2-syntrophin[/E1] are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like [E2]beta 1-syntrophin[/E2], human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 2-syntrophin", "entity_1_idx": [[55, 72]], "entity_1_idx_in_text_with_entity_marker": [59, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta 1-syntrophin", "entity_2_idx": [[209, 226]], "entity_2_idx_in_text_with_entity_marker": [222, 239], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1311_AIMed.d154.s1311.p1", "text": "The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.", "text_with_entity_marker": "The deduced amino acid sequences of human alpha 1- and [E1]beta 2-syntrophin[/E1] are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human [E2]beta 2-syntrophin[/E2] has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 2-syntrophin", "entity_1_idx": [[55, 72]], "entity_1_idx_in_text_with_entity_marker": [59, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta 2-syntrophin", "entity_2_idx": [[234, 251]], "entity_2_idx_in_text_with_entity_marker": [247, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1311_AIMed.d154.s1311.p2", "text": "The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.", "text_with_entity_marker": "The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like [E1]beta 1-syntrophin[/E1], human [E2]beta 2-syntrophin[/E2] has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[209, 226]], "entity_1_idx_in_text_with_entity_marker": [213, 230], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta 2-syntrophin", "entity_2_idx": [[234, 251]], "entity_2_idx_in_text_with_entity_marker": [247, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1313_AIMed.d154.s1313.p0", "text": "Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: beta 2-syntrophin to chromosome 16q22-23 and alpha 1-syntrophin to chromosome 20q11.2.", "text_with_entity_marker": "Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: [E1]beta 2-syntrophin[/E1] to chromosome 16q22-23 and [E2]alpha 1-syntrophin[/E2] to chromosome 20q11.2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 2-syntrophin", "entity_1_idx": [[116, 133]], "entity_1_idx_in_text_with_entity_marker": [120, 137], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "alpha 1-syntrophin", "entity_2_idx": [[161, 179]], "entity_2_idx_in_text_with_entity_marker": [174, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p0", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and [E2]alpha 1-syntrophin[/E2] interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "alpha 1-syntrophin", "entity_2_idx": [[133, 151]], "entity_2_idx_in_text_with_entity_marker": [146, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p1", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p2", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p3", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin[/E2] related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[238, 248]], "entity_2_idx_in_text_with_entity_marker": [251, 261], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p4", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p5", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p6", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p7", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p8", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin[/E2] related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[238, 248]], "entity_2_idx_in_text_with_entity_marker": [251, 261], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p9", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p10", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p11", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p12", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], utrophin/[E2]dystrophin[/E2] related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[238, 248]], "entity_2_idx_in_text_with_entity_marker": [251, 261], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p13", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p14", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], utrophin/dystrophin related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p15", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E1]utrophin[/E1]/[E2]dystrophin[/E2] related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[229, 237]], "entity_1_idx_in_text_with_entity_marker": [233, 241], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[238, 248]], "entity_2_idx_in_text_with_entity_marker": [251, 261], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p16", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E1]utrophin[/E1]/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[229, 237]], "entity_1_idx_in_text_with_entity_marker": [233, 241], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p17", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E1]utrophin[/E1]/dystrophin related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[229, 237]], "entity_1_idx_in_text_with_entity_marker": [233, 241], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p18", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E1-E2]dystrophin[/E1] related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[238, 248]], "entity_1_idx_in_text_with_entity_marker": [245, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin[/E1] related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [245, 276], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p19", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E1]dystrophin[/E1] related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[238, 248]], "entity_1_idx_in_text_with_entity_marker": [242, 252], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p20", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E1]dystrophin related protein[/E1], and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin related protein", "entity_1_idx": [[238, 264]], "entity_1_idx_in_text_with_entity_marker": [242, 268], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p0", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "[E1]Gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin[/E2] receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gastrin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[47, 54]], "entity_2_idx_in_text_with_entity_marker": [60, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p1", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "[E1]Gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin receptor[/E2] substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gastrin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[47, 63]], "entity_2_idx_in_text_with_entity_marker": [60, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p2", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "[E1]Gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin receptor substrate 1[/E2] and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Gastrin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate 1", "entity_2_idx": [[47, 75]], "entity_2_idx_in_text_with_entity_marker": [60, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p3", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "[E1]Gastrin[/E1] stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with [E2]Grb2[/E2] and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gastrin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p4", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "[E1]Gastrin[/E1] stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the [E2]phosphatidylinositol 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gastrin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[114, 143]], "entity_2_idx_in_text_with_entity_marker": [127, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p5", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1-E2]insulin[/E1] receptor[/E2] substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin[/E1] receptor", "entity_2_idx": [[47, 63]], "entity_2_idx_in_text_with_entity_marker": [54, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p6", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1-E2]insulin[/E1] receptor substrate 1[/E2] and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin[/E1] receptor substrate 1", "entity_2_idx": [[47, 75]], "entity_2_idx_in_text_with_entity_marker": [54, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p7", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin[/E1] receptor substrate 1 and its association with [E2]Grb2[/E2] and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p8", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin[/E1] receptor substrate 1 and its association with Grb2 and the [E2]phosphatidylinositol 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[114, 143]], "entity_2_idx_in_text_with_entity_marker": [127, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p9", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1-E2]insulin receptor[/E1] substrate 1[/E2] and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin receptor", "entity_1_idx": [[47, 63]], "entity_1_idx_in_text_with_entity_marker": [54, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor[/E1] substrate 1", "entity_2_idx": [[47, 75]], "entity_2_idx_in_text_with_entity_marker": [54, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p10", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor[/E1] substrate 1 and its association with [E2]Grb2[/E2] and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin receptor", "entity_1_idx": [[47, 63]], "entity_1_idx_in_text_with_entity_marker": [51, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p11", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor[/E1] substrate 1 and its association with Grb2 and the [E2]phosphatidylinositol 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin receptor", "entity_1_idx": [[47, 63]], "entity_1_idx_in_text_with_entity_marker": [51, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[114, 143]], "entity_2_idx_in_text_with_entity_marker": [127, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p12", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] and its association with [E2]Grb2[/E2] and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[47, 75]], "entity_1_idx_in_text_with_entity_marker": [51, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p13", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] and its association with Grb2 and the [E2]phosphatidylinositol 3-kinase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[47, 75]], "entity_1_idx_in_text_with_entity_marker": [51, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[114, 143]], "entity_2_idx_in_text_with_entity_marker": [127, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p14", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with [E1]Grb2[/E1] and the [E2]phosphatidylinositol 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Grb2", "entity_1_idx": [[101, 105]], "entity_1_idx_in_text_with_entity_marker": [105, 109], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[114, 143]], "entity_2_idx_in_text_with_entity_marker": [127, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1520_AIMed.d179.s1520.p0", "text": "The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin/CCKB receptor, which belongs to the family of G protein-coupled receptors.", "text_with_entity_marker": "The growth-promoting effects of [E1]gastrin[/E1] on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the [E2]gastrin[/E2]/CCKB receptor, which belongs to the family of G protein-coupled receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1520_AIMed.d179.s1520.p1", "text": "The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin/CCKB receptor, which belongs to the family of G protein-coupled receptors.", "text_with_entity_marker": "The growth-promoting effects of [E1]gastrin[/E1] on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin/[E2]CCKB receptor[/E2], which belongs to the family of G protein-coupled receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB receptor", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1520_AIMed.d179.s1520.p2", "text": "The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the gastrin/CCKB receptor, which belongs to the family of G protein-coupled receptors.", "text_with_entity_marker": "The growth-promoting effects of gastrin on normal and neoplastic gastrointestinal tissues have been shown to be mediated by the [E1]gastrin[/E1]/[E2]CCKB receptor[/E2], which belongs to the family of G protein-coupled receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[128, 135]], "entity_1_idx_in_text_with_entity_marker": [132, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB receptor", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p0", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin[/E2] receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[89, 96]], "entity_2_idx_in_text_with_entity_marker": [102, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p1", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin receptor substrate 1[/E2] (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate 1", "entity_2_idx": [[89, 117]], "entity_2_idx_in_text_with_entity_marker": [102, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p2", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of insulin receptor substrate 1 ([E2]IRS-1[/E2]), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p3", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[166, 173]], "entity_2_idx_in_text_with_entity_marker": [179, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p4", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[166, 182]], "entity_2_idx_in_text_with_entity_marker": [179, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p5", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1-E2]insulin[/E1] receptor substrate 1[/E2] (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin[/E1] receptor substrate 1", "entity_2_idx": [[89, 117]], "entity_2_idx_in_text_with_entity_marker": [96, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p6", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1]insulin[/E1] receptor substrate 1 ([E2]IRS-1[/E2]), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p7", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1]insulin[/E1] receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[166, 173]], "entity_2_idx_in_text_with_entity_marker": [179, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p8", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1]insulin[/E1] receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[166, 182]], "entity_2_idx_in_text_with_entity_marker": [179, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p9", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] ([E2]IRS-1[/E2]), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[89, 117]], "entity_1_idx_in_text_with_entity_marker": [93, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p10", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] (IRS-1), the major cytoplasmic substrate of the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[89, 117]], "entity_1_idx_in_text_with_entity_marker": [93, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[166, 173]], "entity_2_idx_in_text_with_entity_marker": [179, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p11", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] (IRS-1), the major cytoplasmic substrate of the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[89, 117]], "entity_1_idx_in_text_with_entity_marker": [93, 121], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[166, 182]], "entity_2_idx_in_text_with_entity_marker": [179, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p12", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 ([E1]IRS-1[/E1]), the major cytoplasmic substrate of the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[119, 124]], "entity_1_idx_in_text_with_entity_marker": [123, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[166, 173]], "entity_2_idx_in_text_with_entity_marker": [179, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p13", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 ([E1]IRS-1[/E1]), the major cytoplasmic substrate of the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[119, 124]], "entity_1_idx_in_text_with_entity_marker": [123, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[166, 182]], "entity_2_idx_in_text_with_entity_marker": [179, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p14", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the [E1-E2]insulin[/E1] receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[166, 173]], "entity_1_idx_in_text_with_entity_marker": [173, 180], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin[/E1] receptor", "entity_2_idx": [[166, 182]], "entity_2_idx_in_text_with_entity_marker": [173, 194], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1523_AIMed.d179.s1523.p0", "text": "The gastrin-induced phosphorylation of IRS-1 was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.", "text_with_entity_marker": "The [E1]gastrin[/E1]-induced phosphorylation of [E2]IRS-1[/E2] was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gastrin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p0", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following [E1]gastrin[/E1] stimulation, we observed a time- and dose-dependent association of [E2]IRS-1[/E2] with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[10, 17]], "entity_1_idx_in_text_with_entity_marker": [14, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[85, 90]], "entity_2_idx_in_text_with_entity_marker": [98, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p1", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following [E1]gastrin[/E1] stimulation, we observed a time- and dose-dependent association of IRS-1 with the [E2]p85[/E2] regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[10, 17]], "entity_1_idx_in_text_with_entity_marker": [14, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p2", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following [E1]gastrin[/E1] stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of [E2]phosphatidylinositol 3-kinase[/E2] (PI 3-kinase).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[10, 17]], "entity_1_idx_in_text_with_entity_marker": [14, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[126, 155]], "entity_2_idx_in_text_with_entity_marker": [139, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p3", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following [E1]gastrin[/E1] stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ([E2]PI 3-kinase[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[10, 17]], "entity_1_idx_in_text_with_entity_marker": [14, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[157, 168]], "entity_2_idx_in_text_with_entity_marker": [170, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p4", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of [E1]IRS-1[/E1] with the [E2]p85[/E2] regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p5", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of [E1]IRS-1[/E1] with the p85 regulatory subunit of [E2]phosphatidylinositol 3-kinase[/E2] (PI 3-kinase).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IRS-1", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[126, 155]], "entity_2_idx_in_text_with_entity_marker": [139, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p6", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of [E1]IRS-1[/E1] with the p85 regulatory subunit of phosphatidylinositol 3-kinase ([E2]PI 3-kinase[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IRS-1", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[157, 168]], "entity_2_idx_in_text_with_entity_marker": [170, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p7", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the [E1]p85[/E1] regulatory subunit of [E2]phosphatidylinositol 3-kinase[/E2] (PI 3-kinase).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[126, 155]], "entity_2_idx_in_text_with_entity_marker": [139, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p8", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the [E1]p85[/E1] regulatory subunit of phosphatidylinositol 3-kinase ([E2]PI 3-kinase[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[157, 168]], "entity_2_idx_in_text_with_entity_marker": [170, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p9", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of [E1]phosphatidylinositol 3-kinase[/E1] ([E2]PI 3-kinase[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphatidylinositol 3-kinase", "entity_1_idx": [[126, 155]], "entity_1_idx_in_text_with_entity_marker": [130, 159], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[157, 168]], "entity_2_idx_in_text_with_entity_marker": [170, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p0", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of [E1]PI 3-kinase[/E1] was detected in anti-[E2]IRS-1[/E2] immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI 3-kinase", "entity_1_idx": [[27, 38]], "entity_1_idx_in_text_with_entity_marker": [31, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p1", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of [E1]PI 3-kinase[/E1] was detected in anti-IRS-1 immunoprecipitates from [E2]gastrin[/E2]-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI 3-kinase", "entity_1_idx": [[27, 38]], "entity_1_idx_in_text_with_entity_marker": [31, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p2", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of [E1]PI 3-kinase[/E1] was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of [E2]IRS-1[/E2], which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI 3-kinase", "entity_1_idx": [[27, 38]], "entity_1_idx_in_text_with_entity_marker": [31, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p3", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of [E1]PI 3-kinase[/E1] was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of [E2]p85[/E2], might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI 3-kinase", "entity_1_idx": [[27, 38]], "entity_1_idx_in_text_with_entity_marker": [31, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[204, 207]], "entity_2_idx_in_text_with_entity_marker": [217, 220], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p4", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of [E1]PI 3-kinase[/E1] was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by [E2]gastrin[/E2] to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI 3-kinase", "entity_1_idx": [[27, 38]], "entity_1_idx_in_text_with_entity_marker": [31, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[240, 247]], "entity_2_idx_in_text_with_entity_marker": [253, 260], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p5", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of [E1]PI 3-kinase[/E1] was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate [E2]PI 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI 3-kinase", "entity_1_idx": [[27, 38]], "entity_1_idx_in_text_with_entity_marker": [31, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[260, 271]], "entity_2_idx_in_text_with_entity_marker": [273, 284], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p6", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-[E1]IRS-1[/E1] immunoprecipitates from [E2]gastrin[/E2]-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p7", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-[E1]IRS-1[/E1] immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of [E2]IRS-1[/E2], which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p8", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-[E1]IRS-1[/E1] immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of [E2]p85[/E2], might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[204, 207]], "entity_2_idx_in_text_with_entity_marker": [217, 220], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p9", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-[E1]IRS-1[/E1] immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by [E2]gastrin[/E2] to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[240, 247]], "entity_2_idx_in_text_with_entity_marker": [253, 260], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p10", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-[E1]IRS-1[/E1] immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate [E2]PI 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[260, 271]], "entity_2_idx_in_text_with_entity_marker": [273, 284], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p11", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from [E1]gastrin[/E1]-treated cells, suggesting that tyrosine phosphorylation of [E2]IRS-1[/E2], which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p12", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from [E1]gastrin[/E1]-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of [E2]p85[/E2], might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[204, 207]], "entity_2_idx_in_text_with_entity_marker": [217, 220], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p13", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from [E1]gastrin[/E1]-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by [E2]gastrin[/E2] to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[240, 247]], "entity_2_idx_in_text_with_entity_marker": [253, 260], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p14", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from [E1]gastrin[/E1]-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate [E2]PI 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[260, 271]], "entity_2_idx_in_text_with_entity_marker": [273, 284], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p15", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of [E1]IRS-1[/E1], which leads to the rapid recruitment of [E2]p85[/E2], might be one mechanism used by gastrin to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[204, 207]], "entity_2_idx_in_text_with_entity_marker": [217, 220], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p16", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of [E1]IRS-1[/E1], which leads to the rapid recruitment of p85, might be one mechanism used by [E2]gastrin[/E2] to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[240, 247]], "entity_2_idx_in_text_with_entity_marker": [253, 260], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p17", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of [E1]IRS-1[/E1], which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate [E2]PI 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[260, 271]], "entity_2_idx_in_text_with_entity_marker": [273, 284], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p18", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of [E1]p85[/E1], might be one mechanism used by [E2]gastrin[/E2] to activate PI 3-kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[204, 207]], "entity_1_idx_in_text_with_entity_marker": [208, 211], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[240, 247]], "entity_2_idx_in_text_with_entity_marker": [253, 260], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p19", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of [E1]p85[/E1], might be one mechanism used by gastrin to activate [E2]PI 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[204, 207]], "entity_1_idx_in_text_with_entity_marker": [208, 211], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[260, 271]], "entity_2_idx_in_text_with_entity_marker": [273, 284], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1526_AIMed.d179.s1526.p20", "text": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by gastrin to activate PI 3-kinase.", "text_with_entity_marker": "In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by [E1]gastrin[/E1] to activate [E2]PI 3-kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[240, 247]], "entity_1_idx_in_text_with_entity_marker": [244, 251], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[260, 271]], "entity_2_idx_in_text_with_entity_marker": [273, 284], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p0", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of [E1]Shc[/E1] and its association with the [E2]Grb2[/E2]-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Shc", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p1", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of [E1]Shc[/E1] and its association with the Grb2-[E2]Sos[/E2] complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Shc", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sos", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p2", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of [E1]Shc[/E1] and its association with the Grb2-Sos complex may contribute to the activation of the [E2]mitogen-activated protein kinase[/E2] pathway by gastrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Shc", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[151, 183]], "entity_2_idx_in_text_with_entity_marker": [164, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p3", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of [E1]Shc[/E1] and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by [E2]gastrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Shc", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[195, 202]], "entity_2_idx_in_text_with_entity_marker": [208, 215], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p4", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the [E1]Grb2[/E1]-[E2]Sos[/E2] complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sos", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p5", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the [E1]Grb2[/E1]-Sos complex may contribute to the activation of the [E2]mitogen-activated protein kinase[/E2] pathway by gastrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Grb2", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[151, 183]], "entity_2_idx_in_text_with_entity_marker": [164, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p6", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the [E1]Grb2[/E1]-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by [E2]gastrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Grb2", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[195, 202]], "entity_2_idx_in_text_with_entity_marker": [208, 215], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p7", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-[E1]Sos[/E1] complex may contribute to the activation of the [E2]mitogen-activated protein kinase[/E2] pathway by gastrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Sos", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[151, 183]], "entity_2_idx_in_text_with_entity_marker": [164, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p8", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-[E1]Sos[/E1] complex may contribute to the activation of the mitogen-activated protein kinase pathway by [E2]gastrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Sos", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[195, 202]], "entity_2_idx_in_text_with_entity_marker": [208, 215], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p9", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the [E1]mitogen-activated protein kinase[/E1] pathway by [E2]gastrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[151, 183]], "entity_1_idx_in_text_with_entity_marker": [155, 187], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[195, 202]], "entity_2_idx_in_text_with_entity_marker": [208, 215], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1528_AIMed.d179.s1528.p0", "text": "We report here that Grb2 also interacts with tyrosine-phosphorylated IRS-1 in response to gastrin.", "text_with_entity_marker": "We report here that [E1]Grb2[/E1] also interacts with tyrosine-phosphorylated [E2]IRS-1[/E2] in response to gastrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1528_AIMed.d179.s1528.p1", "text": "We report here that Grb2 also interacts with tyrosine-phosphorylated IRS-1 in response to gastrin.", "text_with_entity_marker": "We report here that [E1]Grb2[/E1] also interacts with tyrosine-phosphorylated IRS-1 in response to [E2]gastrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Grb2", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1528_AIMed.d179.s1528.p2", "text": "We report here that Grb2 also interacts with tyrosine-phosphorylated IRS-1 in response to gastrin.", "text_with_entity_marker": "We report here that Grb2 also interacts with tyrosine-phosphorylated [E1]IRS-1[/E1] in response to [E2]gastrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p0", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E2]gastrin[/E2]/CCKB G protein-coupled receptor and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[177, 184]], "entity_2_idx_in_text_with_entity_marker": [190, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p1", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E2]CCKB[/E2] G protein-coupled receptor and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p2", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E2]CCKB G protein-coupled receptor[/E2] and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB G protein-coupled receptor", "entity_2_idx": [[185, 216]], "entity_2_idx_in_text_with_entity_marker": [198, 229], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p3", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p4", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p5", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/[E2]CCKB[/E2] G protein-coupled receptor and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p6", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/[E2]CCKB G protein-coupled receptor[/E2] and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB G protein-coupled receptor", "entity_2_idx": [[185, 216]], "entity_2_idx_in_text_with_entity_marker": [198, 229], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p7", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/CCKB G protein-coupled receptor and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p8", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/CCKB G protein-coupled receptor and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p9", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1-E2]CCKB[/E1] G protein-coupled receptor[/E2] and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCKB", "entity_1_idx": [[185, 189]], "entity_1_idx_in_text_with_entity_marker": [192, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB[/E1] G protein-coupled receptor", "entity_2_idx": [[185, 216]], "entity_2_idx_in_text_with_entity_marker": [192, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p10", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB[/E1] G protein-coupled receptor and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCKB", "entity_1_idx": [[185, 189]], "entity_1_idx_in_text_with_entity_marker": [189, 193], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p11", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB[/E1] G protein-coupled receptor and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCKB", "entity_1_idx": [[185, 189]], "entity_1_idx_in_text_with_entity_marker": [189, 193], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p12", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB G protein-coupled receptor[/E1] and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCKB G protein-coupled receptor", "entity_1_idx": [[185, 216]], "entity_1_idx_in_text_with_entity_marker": [189, 220], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p13", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB G protein-coupled receptor[/E1] and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCKB G protein-coupled receptor", "entity_1_idx": [[185, 216]], "entity_1_idx_in_text_with_entity_marker": [189, 220], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p14", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the [E1-E2]insulin[/E1] receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[225, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 239], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin[/E1] receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [232, 253], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d33.s277_AIMed.d33.s277.p0", "text": "Native C8 and C9 formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.", "text_with_entity_marker": "Native [E1]C8[/E1] and [E2]C9[/E2] formed a heterodimer in solution of physiological ionic strength with a free-energy change DeltaG degrees of -8.3 kcal/mol and a dissociation constant Kd of 0.6 microM (at 20 degrees C) that was ionic strength- and temperature-dependent.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "C8", "entity_1_idx": [[7, 9]], "entity_1_idx_in_text_with_entity_marker": [11, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "C9", "entity_2_idx": [[14, 16]], "entity_2_idx_in_text_with_entity_marker": [27, 29], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d33.s278_AIMed.d33.s278.p0", "text": "A van't Hoff plot of the change in Kd was linear between 10 and 37 degrees C and yielded values of DeltaH degrees = -12.9 kcal/mol and DeltaS degrees = -15.9 cal mol-1 deg-1, suggesting that electrostatic forces play a prominent role in the interaction of C8 with C9.", "text_with_entity_marker": "A van't Hoff plot of the change in Kd was linear between 10 and 37 degrees C and yielded values of DeltaH degrees = -12.9 kcal/mol and DeltaS degrees = -15.9 cal mol-1 deg-1, suggesting that electrostatic forces play a prominent role in the interaction of [E1]C8[/E1] with [E2]C9[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "C8", "entity_1_idx": [[256, 258]], "entity_1_idx_in_text_with_entity_marker": [260, 262], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "C9", "entity_2_idx": [[264, 266]], "entity_2_idx_in_text_with_entity_marker": [277, 279], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d33.s279_AIMed.d33.s279.p0", "text": "Native C8 also formed a heterodimer with C5,and low concentrations of polyionic ligands such as protamine and suramin inhibited the interaction.", "text_with_entity_marker": "Native [E1]C8[/E1] also formed a heterodimer with [E2]C5[/E2],and low concentrations of polyionic ligands such as protamine and suramin inhibited the interaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "C8", "entity_1_idx": [[7, 9]], "entity_1_idx_in_text_with_entity_marker": [11, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "C5", "entity_2_idx": [[41, 43]], "entity_2_idx_in_text_with_entity_marker": [54, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d33.s280_AIMed.d33.s280.p0", "text": "Suramin induced high-affinity trimerization of C8 (Kd = 0.10 microM at 20 degrees C) and dimerization of C9 (Kd = 0.86 microM at 20 degrees C).", "text_with_entity_marker": "Suramin induced high-affinity trimerization of [E1]C8[/E1] (Kd = 0.10 microM at 20 degrees C) and dimerization of [E2]C9[/E2] (Kd = 0.86 microM at 20 degrees C).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C8", "entity_1_idx": [[47, 49]], "entity_1_idx_in_text_with_entity_marker": [51, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "C9", "entity_2_idx": [[105, 107]], "entity_2_idx_in_text_with_entity_marker": [118, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d33.s282_AIMed.d33.s282.p0", "text": "Analysis of sedimentation equilibria and also of the fluorescence enhancement of suramin when bound to protein provided evidence for two suramin-binding sites on each C9 and three on each C8 in the oligomers.", "text_with_entity_marker": "Analysis of sedimentation equilibria and also of the fluorescence enhancement of suramin when bound to protein provided evidence for two suramin-binding sites on each [E1]C9[/E1] and three on each [E2]C8[/E2] in the oligomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C9", "entity_1_idx": [[167, 169]], "entity_1_idx_in_text_with_entity_marker": [171, 173], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "C8", "entity_2_idx": [[188, 190]], "entity_2_idx_in_text_with_entity_marker": [201, 203], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d89.s753_AIMed.d89.s753.p0", "text": "The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin.", "text_with_entity_marker": "The mitogenic effects of the [E1]B beta chain of fibrinogen[/E1] are mediated through cell surface [E2]calreticulin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "B beta chain of fibrinogen", "entity_1_idx": [[29, 55]], "entity_1_idx_in_text_with_entity_marker": [33, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d89.s761_AIMed.d89.s761.p0", "text": "Immunoprecipitation experiments employing a polyclonal anti-calreticulin antibody provided further evidence that the 60-kDa protein isolated in this study was calreticulin.", "text_with_entity_marker": "Immunoprecipitation experiments employing a polyclonal anti-[E1]calreticulin[/E1] antibody provided further evidence that the 60-kDa protein isolated in this study was [E2]calreticulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calreticulin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[159, 171]], "entity_2_idx_in_text_with_entity_marker": [172, 184], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d89.s762_AIMed.d89.s762.p0", "text": "Further, polyclonal antibodies to human calreticulin significantly inhibited the mitogenic activity of fibrinogen B beta chain on human fibroblasts.", "text_with_entity_marker": "Further, polyclonal antibodies to human [E1]calreticulin[/E1] significantly inhibited the mitogenic activity of [E2]fibrinogen B beta chain[/E2] on human fibroblasts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calreticulin", "entity_1_idx": [[40, 52]], "entity_1_idx_in_text_with_entity_marker": [44, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "fibrinogen B beta chain", "entity_2_idx": [[103, 126]], "entity_2_idx_in_text_with_entity_marker": [116, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d89.s763_AIMed.d89.s763.p0", "text": "The present study has shown that cell surface calreticulin binds to the B beta chain of fibrinogen mediating its mitogenic activity.", "text_with_entity_marker": "The present study has shown that cell surface [E1]calreticulin[/E1] binds to the [E2]B beta chain of fibrinogen[/E2] mediating its mitogenic activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "calreticulin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "B beta chain of fibrinogen", "entity_2_idx": [[72, 98]], "entity_2_idx_in_text_with_entity_marker": [85, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1872_AIMed.d216.s1872.p0", "text": "The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.", "text_with_entity_marker": "The [E1]Ras[/E1]-[E2]RasGAP[/E2] complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RasGAP", "entity_2_idx": [[8, 14]], "entity_2_idx_in_text_with_entity_marker": [21, 27], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1872_AIMed.d216.s1872.p1", "text": "The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.", "text_with_entity_marker": "The [E1]Ras[/E1]-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic [E2]Ras[/E2] mutants.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[89, 92]], "entity_2_idx_in_text_with_entity_marker": [102, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1872_AIMed.d216.s1872.p2", "text": "The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.", "text_with_entity_marker": "The Ras-[E1]RasGAP[/E1] complex: structural basis for GTPase activation and its loss in oncogenic [E2]Ras[/E2] mutants.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RasGAP", "entity_1_idx": [[8, 14]], "entity_1_idx_in_text_with_entity_marker": [12, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[89, 92]], "entity_2_idx_in_text_with_entity_marker": [102, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p0", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human [E1]H-Ras[/E1] bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human [E2]GTPase-activating protein[/E2] p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H-Ras", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GTPase-activating protein", "entity_2_idx": [[171, 196]], "entity_2_idx_in_text_with_entity_marker": [184, 209], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p1", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human [E1]H-Ras[/E1] bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein [E2]p120GAP[/E2] (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H-Ras", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p120GAP", "entity_2_idx": [[197, 204]], "entity_2_idx_in_text_with_entity_marker": [210, 217], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p2", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human [E1]H-Ras[/E1] bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP ([E2]GAP-334[/E2]) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H-Ras", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GAP-334", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p3", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human [E1]GTPase-activating protein[/E1] [E2]p120GAP[/E2] (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GTPase-activating protein", "entity_1_idx": [[171, 196]], "entity_1_idx_in_text_with_entity_marker": [175, 200], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p120GAP", "entity_2_idx": [[197, 204]], "entity_2_idx_in_text_with_entity_marker": [210, 217], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p4", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human [E1]GTPase-activating protein[/E1] p120GAP ([E2]GAP-334[/E2]) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GTPase-activating protein", "entity_1_idx": [[171, 196]], "entity_1_idx_in_text_with_entity_marker": [175, 200], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GAP-334", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p5", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein [E1]p120GAP[/E1] ([E2]GAP-334[/E2]) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120GAP", "entity_1_idx": [[197, 204]], "entity_1_idx_in_text_with_entity_marker": [201, 208], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GAP-334", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1875_AIMed.d216.s1875.p0", "text": "An arginine side chain (arginine-789) of GAP-334 is supplied into the active site of Ras to neutralize developing charges in the transition state.", "text_with_entity_marker": "An arginine side chain (arginine-789) of [E1]GAP-334[/E1] is supplied into the active site of [E2]Ras[/E2] to neutralize developing charges in the transition state.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GAP-334", "entity_1_idx": [[41, 48]], "entity_1_idx_in_text_with_entity_marker": [45, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[85, 88]], "entity_2_idx_in_text_with_entity_marker": [98, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1876_AIMed.d216.s1876.p0", "text": "The switch II region of Ras is stabilized by GAP-334, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.", "text_with_entity_marker": "The switch II region of [E1]Ras[/E1] is stabilized by [E2]GAP-334[/E2], thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GAP-334", "entity_2_idx": [[45, 52]], "entity_2_idx_in_text_with_entity_marker": [58, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1876_AIMed.d216.s1876.p1", "text": "The switch II region of Ras is stabilized by GAP-334, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.", "text_with_entity_marker": "The switch II region of [E1]Ras[/E1] is stabilized by GAP-334, thus allowing glutamine-61 of [E2]Ras[/E2], mutation of which activates the oncogenic potential, to participate in catalysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1876_AIMed.d216.s1876.p2", "text": "The switch II region of Ras is stabilized by GAP-334, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.", "text_with_entity_marker": "The switch II region of Ras is stabilized by [E1]GAP-334[/E1], thus allowing glutamine-61 of [E2]Ras[/E2], mutation of which activates the oncogenic potential, to participate in catalysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GAP-334", "entity_1_idx": [[45, 52]], "entity_1_idx_in_text_with_entity_marker": [49, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1878_AIMed.d216.s1878.p0", "text": "Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of GAP-334 and glutamine-61 of Ras, and even its mutation to alanine would disturb the arrangements of residues in the transition state.", "text_with_entity_marker": "Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of [E1]GAP-334[/E1] and glutamine-61 of [E2]Ras[/E2], and even its mutation to alanine would disturb the arrangements of residues in the transition state.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GAP-334", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[126, 129]], "entity_2_idx_in_text_with_entity_marker": [139, 142], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1846_AIMed.d213.s1846.p0", "text": "In addition, previous work indicated that p300 and CBP might be involved in YY1-mediated repression.", "text_with_entity_marker": "In addition, previous work indicated that [E1]p300[/E1] and [E2]CBP[/E2] might be involved in YY1-mediated repression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[51, 54]], "entity_2_idx_in_text_with_entity_marker": [64, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1846_AIMed.d213.s1846.p1", "text": "In addition, previous work indicated that p300 and CBP might be involved in YY1-mediated repression.", "text_with_entity_marker": "In addition, previous work indicated that [E1]p300[/E1] and CBP might be involved in [E2]YY1[/E2]-mediated repression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "YY1", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1846_AIMed.d213.s1846.p2", "text": "In addition, previous work indicated that p300 and CBP might be involved in YY1-mediated repression.", "text_with_entity_marker": "In addition, previous work indicated that p300 and [E1]CBP[/E1] might be involved in [E2]YY1[/E2]-mediated repression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "YY1", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p0", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between [E1]YY1[/E1] and [E2]p300[/E2], a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "YY1", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[54, 58]], "entity_2_idx_in_text_with_entity_marker": [67, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p1", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between [E1]YY1[/E1] and p300, a coactivator for [E2]CREB[/E2], is not sufficient for repression of CREB-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "YY1", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[78, 82]], "entity_2_idx_in_text_with_entity_marker": [91, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p2", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between [E1]YY1[/E1] and p300, a coactivator for CREB, is not sufficient for repression of [E2]CREB[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "YY1", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p3", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between YY1 and [E1]p300[/E1], a coactivator for [E2]CREB[/E2], is not sufficient for repression of CREB-mediated transcription.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[78, 82]], "entity_2_idx_in_text_with_entity_marker": [91, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p4", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between YY1 and [E1]p300[/E1], a coactivator for CREB, is not sufficient for repression of [E2]CREB[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1851_AIMed.d213.s1851.p5", "text": "We show that the physical interaction between YY1 and p300, a coactivator for CREB, is not sufficient for repression of CREB-mediated transcription.", "text_with_entity_marker": "We show that the physical interaction between YY1 and p300, a coactivator for [E1]CREB[/E1], is not sufficient for repression of [E2]CREB[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[78, 82]], "entity_1_idx_in_text_with_entity_marker": [82, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1853_AIMed.d213.s1853.p0", "text": "Repression of CTF-1-directed transcription may be accomplished through direct physical interaction between YY1 and this activator.", "text_with_entity_marker": "Repression of [E1]CTF-1[/E1]-directed transcription may be accomplished through direct physical interaction between [E2]YY1[/E2] and this activator.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CTF-1", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "YY1", "entity_2_idx": [[107, 110]], "entity_2_idx_in_text_with_entity_marker": [120, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1854_AIMed.d213.s1854.p0", "text": "In contrast, physical interaction is not necessary for YY1 to repress Sp1- and CREB-mediated transcription.", "text_with_entity_marker": "In contrast, physical interaction is not necessary for [E1]YY1[/E1] to repress [E2]Sp1[/E2]- and CREB-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "YY1", "entity_1_idx": [[55, 58]], "entity_1_idx_in_text_with_entity_marker": [59, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sp1", "entity_2_idx": [[70, 73]], "entity_2_idx_in_text_with_entity_marker": [83, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1854_AIMed.d213.s1854.p1", "text": "In contrast, physical interaction is not necessary for YY1 to repress Sp1- and CREB-mediated transcription.", "text_with_entity_marker": "In contrast, physical interaction is not necessary for [E1]YY1[/E1] to repress Sp1- and [E2]CREB[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "YY1", "entity_1_idx": [[55, 58]], "entity_1_idx_in_text_with_entity_marker": [59, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d213.s1854_AIMed.d213.s1854.p2", "text": "In contrast, physical interaction is not necessary for YY1 to repress Sp1- and CREB-mediated transcription.", "text_with_entity_marker": "In contrast, physical interaction is not necessary for YY1 to repress [E1]Sp1[/E1]- and [E2]CREB[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Sp1", "entity_1_idx": [[70, 73]], "entity_1_idx_in_text_with_entity_marker": [74, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s544_AIMed.d63.s544.p0", "text": "Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.", "text_with_entity_marker": "Coassociation of [E1]CD26[/E1] ([E2]dipeptidyl peptidase IV[/E2]) with CD45 on the surface of human T lymphocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[17, 21]], "entity_1_idx_in_text_with_entity_marker": [21, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[23, 46]], "entity_2_idx_in_text_with_entity_marker": [36, 59], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s544_AIMed.d63.s544.p1", "text": "Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.", "text_with_entity_marker": "Coassociation of [E1]CD26[/E1] (dipeptidyl peptidase IV) with [E2]CD45[/E2] on the surface of human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[17, 21]], "entity_1_idx_in_text_with_entity_marker": [21, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s544_AIMed.d63.s544.p2", "text": "Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.", "text_with_entity_marker": "Coassociation of CD26 ([E1]dipeptidyl peptidase IV[/E1]) with [E2]CD45[/E2] on the surface of human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[23, 46]], "entity_1_idx_in_text_with_entity_marker": [27, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s545_AIMed.d63.s545.p0", "text": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "text_with_entity_marker": "In the present report, we demonstrated that modulation of [E1]CD26[/E1] from T cell surface induced by anti[E2]CD26[/E2] (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[58, 62]], "entity_1_idx_in_text_with_entity_marker": [62, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s545_AIMed.d63.s545.p1", "text": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "text_with_entity_marker": "In the present report, we demonstrated that modulation of [E1]CD26[/E1] from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of [E2]CD3[/E2] zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[58, 62]], "entity_1_idx_in_text_with_entity_marker": [62, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s545_AIMed.d63.s545.p2", "text": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "text_with_entity_marker": "In the present report, we demonstrated that modulation of [E1]CD26[/E1] from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased [E2]CD4[/E2] associated p56lck tyrosine kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[58, 62]], "entity_1_idx_in_text_with_entity_marker": [62, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD4", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s545_AIMed.d63.s545.p3", "text": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "text_with_entity_marker": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by anti[E1]CD26[/E1] (1F7) led to enhanced phosphorylation of [E2]CD3[/E2] zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[98, 102]], "entity_1_idx_in_text_with_entity_marker": [102, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s545_AIMed.d63.s545.p4", "text": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "text_with_entity_marker": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by anti[E1]CD26[/E1] (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased [E2]CD4[/E2] associated p56lck tyrosine kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[98, 102]], "entity_1_idx_in_text_with_entity_marker": [102, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD4", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s545_AIMed.d63.s545.p5", "text": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of CD3 zeta tyrosine residues and increased CD4 associated p56lck tyrosine kinase activity.", "text_with_entity_marker": "In the present report, we demonstrated that modulation of CD26 from T cell surface induced by antiCD26 (1F7) led to enhanced phosphorylation of [E1]CD3[/E1] zeta tyrosine residues and increased [E2]CD4[/E2] associated p56lck tyrosine kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD3", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD4", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s546_AIMed.d63.s546.p0", "text": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "text_with_entity_marker": "We further showed that [E1]CD26[/E1] was comodulated on the T cell surface with [E2]CD45[/E2], a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[71, 75]], "entity_2_idx_in_text_with_entity_marker": [84, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s546_AIMed.d63.s546.p1", "text": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "text_with_entity_marker": "We further showed that [E1]CD26[/E1] was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-[E2]CD26[/E2] was capable of precipitating CD45 from T cell lysates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s546_AIMed.d63.s546.p2", "text": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "text_with_entity_marker": "We further showed that [E1]CD26[/E1] was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating [E2]CD45[/E2] from T cell lysates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[178, 182]], "entity_2_idx_in_text_with_entity_marker": [191, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s546_AIMed.d63.s546.p3", "text": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "text_with_entity_marker": "We further showed that CD26 was comodulated on the T cell surface with [E1]CD45[/E1], a known membrane-linked protein tyrosine phosphatase and that anti-[E2]CD26[/E2] was capable of precipitating CD45 from T cell lysates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD45", "entity_1_idx": [[71, 75]], "entity_1_idx_in_text_with_entity_marker": [75, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s546_AIMed.d63.s546.p4", "text": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "text_with_entity_marker": "We further showed that CD26 was comodulated on the T cell surface with [E1]CD45[/E1], a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating [E2]CD45[/E2] from T cell lysates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD45", "entity_1_idx": [[71, 75]], "entity_1_idx_in_text_with_entity_marker": [75, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[178, 182]], "entity_2_idx_in_text_with_entity_marker": [191, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s546_AIMed.d63.s546.p5", "text": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating CD45 from T cell lysates.", "text_with_entity_marker": "We further showed that CD26 was comodulated on the T cell surface with CD45, a known membrane-linked protein tyrosine phosphatase and that anti-[E1]CD26[/E1] was capable of precipitating [E2]CD45[/E2] from T cell lysates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[178, 182]], "entity_2_idx_in_text_with_entity_marker": [191, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p0", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that [E1]CD26[/E1] may be closely associated with the [E2]CD45[/E2] protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p1", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that [E1]CD26[/E1] may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of [E2]CD26[/E2] with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p2", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that [E1]CD26[/E1] may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with [E2]CD45[/E2] results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[194, 198]], "entity_2_idx_in_text_with_entity_marker": [207, 211], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p3", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that CD26 may be closely associated with the [E1]CD45[/E1] protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of [E2]CD26[/E2] with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD45", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p4", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that CD26 may be closely associated with the [E1]CD45[/E1] protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with [E2]CD45[/E2] results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD45", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[194, 198]], "entity_2_idx_in_text_with_entity_marker": [207, 211], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p5", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of [E1]CD26[/E1] with [E2]CD45[/E2] results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[194, 198]], "entity_2_idx_in_text_with_entity_marker": [207, 211], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s930_AIMed.d111.s930.p0", "text": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "text_with_entity_marker": "Mutagenesis of the regulatory subunit ([E1]RII beta[/E1]) of [E2]cAMP-dependent protein kinase II beta[/E2] reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cAMP-dependent protein kinase II beta", "entity_2_idx": [[52, 89]], "entity_2_idx_in_text_with_entity_marker": [65, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s930_AIMed.d111.s930.p1", "text": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "text_with_entity_marker": "Mutagenesis of the regulatory subunit ([E1]RII beta[/E1]) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for [E2]RII beta[/E2] dimerization and/or anchoring RII beta to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s930_AIMed.d111.s930.p2", "text": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "text_with_entity_marker": "Mutagenesis of the regulatory subunit ([E1]RII beta[/E1]) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring [E2]RII beta[/E2] to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[184, 192]], "entity_2_idx_in_text_with_entity_marker": [197, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s930_AIMed.d111.s930.p3", "text": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "text_with_entity_marker": "Mutagenesis of the regulatory subunit (RII beta) of [E1]cAMP-dependent protein kinase II beta[/E1] reveals hydrophobic amino acids that are essential for [E2]RII beta[/E2] dimerization and/or anchoring RII beta to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cAMP-dependent protein kinase II beta", "entity_1_idx": [[52, 89]], "entity_1_idx_in_text_with_entity_marker": [56, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s930_AIMed.d111.s930.p4", "text": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "text_with_entity_marker": "Mutagenesis of the regulatory subunit (RII beta) of [E1]cAMP-dependent protein kinase II beta[/E1] reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring [E2]RII beta[/E2] to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cAMP-dependent protein kinase II beta", "entity_1_idx": [[52, 89]], "entity_1_idx_in_text_with_entity_marker": [56, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[184, 192]], "entity_2_idx_in_text_with_entity_marker": [197, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s930_AIMed.d111.s930.p5", "text": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for RII beta dimerization and/or anchoring RII beta to the cytoskeleton.", "text_with_entity_marker": "Mutagenesis of the regulatory subunit (RII beta) of cAMP-dependent protein kinase II beta reveals hydrophobic amino acids that are essential for [E1]RII beta[/E1] dimerization and/or anchoring [E2]RII beta[/E2] to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[145, 153]], "entity_1_idx_in_text_with_entity_marker": [149, 157], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[184, 192]], "entity_2_idx_in_text_with_entity_marker": [197, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s931_AIMed.d111.s931.p0", "text": "In neurons cAMP-dependent protein kinase II beta (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).", "text_with_entity_marker": "In neurons [E1]cAMP-dependent protein kinase II beta[/E1] ([E2]PKAII beta[/E2]) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cAMP-dependent protein kinase II beta", "entity_1_idx": [[11, 48]], "entity_1_idx_in_text_with_entity_marker": [15, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PKAII beta", "entity_2_idx": [[50, 60]], "entity_2_idx_in_text_with_entity_marker": [63, 73], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s931_AIMed.d111.s931.p1", "text": "In neurons cAMP-dependent protein kinase II beta (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).", "text_with_entity_marker": "In neurons [E1]cAMP-dependent protein kinase II beta[/E1] (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit ([E2]RII beta[/E2]) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cAMP-dependent protein kinase II beta", "entity_1_idx": [[11, 48]], "entity_1_idx_in_text_with_entity_marker": [15, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s931_AIMed.d111.s931.p2", "text": "In neurons cAMP-dependent protein kinase II beta (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).", "text_with_entity_marker": "In neurons cAMP-dependent protein kinase II beta ([E1]PKAII beta[/E1]) is sequestered in the dendritic cytoskeleton because the regulatory subunit ([E2]RII beta[/E2]) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKAII beta", "entity_1_idx": [[50, 60]], "entity_1_idx_in_text_with_entity_marker": [54, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s932_AIMed.d111.s932.p0", "text": "The prototypic neuronal anchor protein AKAP75 has a COOH-terminal 22-residue RII beta binding (tethering) site.", "text_with_entity_marker": "The prototypic neuronal anchor protein [E1]AKAP75[/E1] has a COOH-terminal 22-residue [E2]RII beta[/E2] binding (tethering) site.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AKAP75", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[77, 85]], "entity_2_idx_in_text_with_entity_marker": [90, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s934_AIMed.d111.s934.p0", "text": "Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and AKAP75 binding activities of RII beta.", "text_with_entity_marker": "Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and [E1]AKAP75[/E1] binding activities of [E2]RII beta[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AKAP75", "entity_1_idx": [[157, 163]], "entity_1_idx_in_text_with_entity_marker": [161, 167], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s936_AIMed.d111.s936.p0", "text": "Substitution of Ala for Leu13 or Phe36 generates monomeric RII beta subunits that cannot bind AKAP75.", "text_with_entity_marker": "Substitution of Ala for Leu13 or Phe36 generates monomeric [E1]RII beta[/E1] subunits that cannot bind [E2]AKAP75[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP75", "entity_2_idx": [[94, 100]], "entity_2_idx_in_text_with_entity_marker": [107, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s937_AIMed.d111.s937.p0", "text": "The results are not due to general misfolding since mutant RII beta monomers bind cAMP and inhibit the catalytic subunit of PKAII beta with the same affinity and efficacy as wild-type RII beta dimers.", "text_with_entity_marker": "The results are not due to general misfolding since mutant [E1]RII beta[/E1] monomers bind cAMP and inhibit the catalytic subunit of [E2]PKAII beta[/E2] with the same affinity and efficacy as wild-type RII beta dimers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PKAII beta", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s937_AIMed.d111.s937.p1", "text": "The results are not due to general misfolding since mutant RII beta monomers bind cAMP and inhibit the catalytic subunit of PKAII beta with the same affinity and efficacy as wild-type RII beta dimers.", "text_with_entity_marker": "The results are not due to general misfolding since mutant [E1]RII beta[/E1] monomers bind cAMP and inhibit the catalytic subunit of PKAII beta with the same affinity and efficacy as wild-type [E2]RII beta[/E2] dimers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[184, 192]], "entity_2_idx_in_text_with_entity_marker": [197, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s937_AIMed.d111.s937.p2", "text": "The results are not due to general misfolding since mutant RII beta monomers bind cAMP and inhibit the catalytic subunit of PKAII beta with the same affinity and efficacy as wild-type RII beta dimers.", "text_with_entity_marker": "The results are not due to general misfolding since mutant RII beta monomers bind cAMP and inhibit the catalytic subunit of [E1]PKAII beta[/E1] with the same affinity and efficacy as wild-type [E2]RII beta[/E2] dimers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKAII beta", "entity_1_idx": [[124, 134]], "entity_1_idx_in_text_with_entity_marker": [128, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[184, 192]], "entity_2_idx_in_text_with_entity_marker": [197, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s939_AIMed.d111.s939.p0", "text": "Evidently, large hydrophobic side chains of Leu13 and Phe36 play pivotal roles in stabilizing RII beta-RII beta interactions.", "text_with_entity_marker": "Evidently, large hydrophobic side chains of Leu13 and Phe36 play pivotal roles in stabilizing [E1]RII beta[/E1]-[E2]RII beta[/E2] interactions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RII beta", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s940_AIMed.d111.s940.p0", "text": "A secondary consequence of destabilizing RII beta dimers is the loss of intracellular targeting/anchoring capacity because monomers fail to bind AKAP75.", "text_with_entity_marker": "A secondary consequence of destabilizing [E1]RII beta[/E1] dimers is the loss of intracellular targeting/anchoring capacity because monomers fail to bind [E2]AKAP75[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP75", "entity_2_idx": [[145, 151]], "entity_2_idx_in_text_with_entity_marker": [158, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s941_AIMed.d111.s941.p0", "text": "Other NH2-terminal residues directly modulate the affinity of RII beta dimers for the AKAP75 tethering site.", "text_with_entity_marker": "Other NH2-terminal residues directly modulate the affinity of [E1]RII beta[/E1] dimers for the [E2]AKAP75[/E2] tethering site.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RII beta", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP75", "entity_2_idx": [[86, 92]], "entity_2_idx_in_text_with_entity_marker": [99, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s942_AIMed.d111.s942.p0", "text": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 approximately 4% as avidly as wild-type RII beta.", "text_with_entity_marker": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric [E1]RII beta[/E1] protein that binds [E2]AKAP75[/E2] approximately 4% as avidly as wild-type RII beta.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RII beta", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP75", "entity_2_idx": [[87, 93]], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s942_AIMed.d111.s942.p1", "text": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 approximately 4% as avidly as wild-type RII beta.", "text_with_entity_marker": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric [E1]RII beta[/E1] protein that binds AKAP75 approximately 4% as avidly as wild-type [E2]RII beta[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s942_AIMed.d111.s942.p2", "text": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 approximately 4% as avidly as wild-type RII beta.", "text_with_entity_marker": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds [E1]AKAP75[/E1] approximately 4% as avidly as wild-type [E2]RII beta[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AKAP75", "entity_1_idx": [[87, 93]], "entity_1_idx_in_text_with_entity_marker": [91, 97], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p0", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated [E1]collagenase I[/E1] ([E2]MMP-1[/E2]) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagenase I", "entity_1_idx": [[34, 47]], "entity_1_idx_in_text_with_entity_marker": [38, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p1", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated [E1]collagenase I[/E1] (MMP-1) is absolutely required for interaction with its specific inhibitor, [E2]tissue inhibitor of metalloproteinases-1[/E2] (TIMP-1).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagenase I", "entity_1_idx": [[34, 47]], "entity_1_idx_in_text_with_entity_marker": [38, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tissue inhibitor of metalloproteinases-1", "entity_2_idx": [[124, 164]], "entity_2_idx_in_text_with_entity_marker": [137, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p2", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated [E1]collagenase I[/E1] (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 ([E2]TIMP-1[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagenase I", "entity_1_idx": [[34, 47]], "entity_1_idx_in_text_with_entity_marker": [38, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p3", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated collagenase I ([E1]MMP-1[/E1]) is absolutely required for interaction with its specific inhibitor, [E2]tissue inhibitor of metalloproteinases-1[/E2] (TIMP-1).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tissue inhibitor of metalloproteinases-1", "entity_2_idx": [[124, 164]], "entity_2_idx_in_text_with_entity_marker": [137, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p4", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated collagenase I ([E1]MMP-1[/E1]) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 ([E2]TIMP-1[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1756_AIMed.d204.s1756.p5", "text": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).", "text_with_entity_marker": "The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, [E1]tissue inhibitor of metalloproteinases-1[/E1] ([E2]TIMP-1[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tissue inhibitor of metalloproteinases-1", "entity_1_idx": [[124, 164]], "entity_1_idx_in_text_with_entity_marker": [128, 168], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1757_AIMed.d204.s1757.p0", "text": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "text_with_entity_marker": "Here, we describe the production of [E1]recombinant human tissue inhibitor of metalloproteinases-1[/E1] ([E2]rTIMP-1[/E2]) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "recombinant human tissue inhibitor of metalloproteinases-1", "entity_1_idx": [[36, 94]], "entity_1_idx_in_text_with_entity_marker": [40, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "rTIMP-1", "entity_2_idx": [[96, 103]], "entity_2_idx_in_text_with_entity_marker": [109, 116], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1757_AIMed.d204.s1757.p1", "text": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "text_with_entity_marker": "Here, we describe the production of [E1]recombinant human tissue inhibitor of metalloproteinases-1[/E1] (rTIMP-1) and wild-type and mutant human [E2]collagenase type I[/E2] (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "recombinant human tissue inhibitor of metalloproteinases-1", "entity_1_idx": [[36, 94]], "entity_1_idx_in_text_with_entity_marker": [40, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "collagenase type I", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1757_AIMed.d204.s1757.p2", "text": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "text_with_entity_marker": "Here, we describe the production of [E1]recombinant human tissue inhibitor of metalloproteinases-1[/E1] (rTIMP-1) and wild-type and mutant human collagenase type I ([E2]rMMP-1[/E2]) proteins in SF9 cells by the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "recombinant human tissue inhibitor of metalloproteinases-1", "entity_1_idx": [[36, 94]], "entity_1_idx_in_text_with_entity_marker": [40, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "rMMP-1", "entity_2_idx": [[156, 162]], "entity_2_idx_in_text_with_entity_marker": [169, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1757_AIMed.d204.s1757.p3", "text": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "text_with_entity_marker": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ([E1]rTIMP-1[/E1]) and wild-type and mutant human [E2]collagenase type I[/E2] (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rTIMP-1", "entity_1_idx": [[96, 103]], "entity_1_idx_in_text_with_entity_marker": [100, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "collagenase type I", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1757_AIMed.d204.s1757.p4", "text": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "text_with_entity_marker": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ([E1]rTIMP-1[/E1]) and wild-type and mutant human collagenase type I ([E2]rMMP-1[/E2]) proteins in SF9 cells by the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rTIMP-1", "entity_1_idx": [[96, 103]], "entity_1_idx_in_text_with_entity_marker": [100, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "rMMP-1", "entity_2_idx": [[156, 162]], "entity_2_idx_in_text_with_entity_marker": [169, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1757_AIMed.d204.s1757.p5", "text": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human collagenase type I (rMMP-1) proteins in SF9 cells by the baculovirus expression system.", "text_with_entity_marker": "Here, we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 (rTIMP-1) and wild-type and mutant human [E1]collagenase type I[/E1] ([E2]rMMP-1[/E2]) proteins in SF9 cells by the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagenase type I", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "rMMP-1", "entity_2_idx": [[156, 162]], "entity_2_idx_in_text_with_entity_marker": [169, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1758_AIMed.d204.s1758.p0", "text": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "text_with_entity_marker": "Wild-type [E1]MMP-1[/E1], as well as the [E2]MMP-1[/E2] mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1758_AIMed.d204.s1758.p1", "text": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "text_with_entity_marker": "Wild-type [E1]MMP-1[/E1], as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-[E2]MMP-1[/E2]], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1758_AIMed.d204.s1758.p2", "text": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "text_with_entity_marker": "Wild-type [E1]MMP-1[/E1], as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with [E2]trypsin[/E2] or 4-aminophenylmercuric acetate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "trypsin", "entity_2_idx": [[189, 196]], "entity_2_idx_in_text_with_entity_marker": [202, 209], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1758_AIMed.d204.s1758.p3", "text": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "text_with_entity_marker": "Wild-type MMP-1, as well as the [E1]MMP-1[/E1] mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-[E2]MMP-1[/E2]], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1758_AIMed.d204.s1758.p4", "text": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "text_with_entity_marker": "Wild-type MMP-1, as well as the [E1]MMP-1[/E1] mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with [E2]trypsin[/E2] or 4-aminophenylmercuric acetate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "trypsin", "entity_2_idx": [[189, 196]], "entity_2_idx_in_text_with_entity_marker": [202, 209], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1758_AIMed.d204.s1758.p5", "text": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.", "text_with_entity_marker": "Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-[E1]MMP-1[/E1]], exhibit enzymatic activity upon cleavage of the prodomain by treatment with [E2]trypsin[/E2] or 4-aminophenylmercuric acetate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "trypsin", "entity_2_idx": [[189, 196]], "entity_2_idx_in_text_with_entity_marker": [202, 209], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1760_AIMed.d204.s1760.p0", "text": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or beta-casein.", "text_with_entity_marker": "Deletion of the complete active-site [des-(161-228)-[E1]MMP-1[/E1]] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of [E2]MMP-1[/E2] proteins which are unable to digest collagen type I or beta-casein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1760_AIMed.d204.s1760.p1", "text": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or beta-casein.", "text_with_entity_marker": "Deletion of the complete active-site [des-(161-228)-[E1]MMP-1[/E1]] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest [E2]collagen type I[/E2] or beta-casein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "collagen type I", "entity_2_idx": [[229, 244]], "entity_2_idx_in_text_with_entity_marker": [242, 257], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1760_AIMed.d204.s1760.p2", "text": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or beta-casein.", "text_with_entity_marker": "Deletion of the complete active-site [des-(161-228)-[E1]MMP-1[/E1]] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or [E2]beta-casein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta-casein", "entity_2_idx": [[248, 259]], "entity_2_idx_in_text_with_entity_marker": [261, 272], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1760_AIMed.d204.s1760.p3", "text": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or beta-casein.", "text_with_entity_marker": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of [E1]MMP-1[/E1] proteins which are unable to digest [E2]collagen type I[/E2] or beta-casein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[187, 192]], "entity_1_idx_in_text_with_entity_marker": [191, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "collagen type I", "entity_2_idx": [[229, 244]], "entity_2_idx_in_text_with_entity_marker": [242, 257], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1760_AIMed.d204.s1760.p4", "text": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or beta-casein.", "text_with_entity_marker": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of [E1]MMP-1[/E1] proteins which are unable to digest collagen type I or [E2]beta-casein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[187, 192]], "entity_1_idx_in_text_with_entity_marker": [191, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta-casein", "entity_2_idx": [[248, 259]], "entity_2_idx_in_text_with_entity_marker": [261, 272], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1760_AIMed.d204.s1760.p5", "text": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest collagen type I or beta-casein.", "text_with_entity_marker": "Deletion of the complete active-site [des-(161-228)-MMP-1] within the catalytic domain, or mutation of a single His residue of the Zn2+ binding domain (His199), generates stable forms of MMP-1 proteins which are unable to digest [E1]collagen type I[/E1] or [E2]beta-casein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagen type I", "entity_1_idx": [[229, 244]], "entity_1_idx_in_text_with_entity_marker": [233, 248], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta-casein", "entity_2_idx": [[248, 259]], "entity_2_idx_in_text_with_entity_marker": [261, 272], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1761_AIMed.d204.s1761.p0", "text": "In addition to co-immunoprecipitation analysis, we have established a rapid and sensitive ELISA assay using immobilized rTIMP to determine the structural requirements of MMP-1 to form complexes with its inhibitor.", "text_with_entity_marker": "In addition to co-immunoprecipitation analysis, we have established a rapid and sensitive ELISA assay using immobilized [E1]rTIMP[/E1] to determine the structural requirements of [E2]MMP-1[/E2] to form complexes with its inhibitor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rTIMP", "entity_1_idx": [[120, 125]], "entity_1_idx_in_text_with_entity_marker": [124, 129], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1762_AIMed.d204.s1762.p0", "text": "Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)-MMP-1 proteins are able to form complexes with TIMP.", "text_with_entity_marker": "Only the activated and not the latent forms of wild-type and C-terminal mutant des-(248-450)-[E1]MMP-1[/E1] proteins are able to form complexes with [E2]TIMP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP", "entity_2_idx": [[140, 144]], "entity_2_idx_in_text_with_entity_marker": [153, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1763_AIMed.d204.s1763.p0", "text": "Neither mutation of His199, nor deletion mutants des-(161-228)-MMP-1 and des-(161-228/248-450)-MMP-1, interact with TIMP.", "text_with_entity_marker": "Neither mutation of His199, nor deletion mutants des-(161-228)-[E1]MMP-1[/E1] and des-(161-228/248-450)-[E2]MMP-1[/E2], interact with TIMP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[95, 100]], "entity_2_idx_in_text_with_entity_marker": [108, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1763_AIMed.d204.s1763.p1", "text": "Neither mutation of His199, nor deletion mutants des-(161-228)-MMP-1 and des-(161-228/248-450)-MMP-1, interact with TIMP.", "text_with_entity_marker": "Neither mutation of His199, nor deletion mutants des-(161-228)-[E1]MMP-1[/E1] and des-(161-228/248-450)-MMP-1, interact with [E2]TIMP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP", "entity_2_idx": [[116, 120]], "entity_2_idx_in_text_with_entity_marker": [129, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1763_AIMed.d204.s1763.p2", "text": "Neither mutation of His199, nor deletion mutants des-(161-228)-MMP-1 and des-(161-228/248-450)-MMP-1, interact with TIMP.", "text_with_entity_marker": "Neither mutation of His199, nor deletion mutants des-(161-228)-MMP-1 and des-(161-228/248-450)-[E1]MMP-1[/E1], interact with [E2]TIMP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[95, 100]], "entity_1_idx_in_text_with_entity_marker": [99, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP", "entity_2_idx": [[116, 120]], "entity_2_idx_in_text_with_entity_marker": [129, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p0", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of [E1]MMP-1[/E1], in contrast to the corresponding regions of [E2]gelatinase A[/E2] and gelatinase B, does not interact with TIMP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gelatinase A", "entity_2_idx": [[109, 121]], "entity_2_idx_in_text_with_entity_marker": [122, 134], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p1", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of [E1]MMP-1[/E1], in contrast to the corresponding regions of gelatinase A and [E2]gelatinase B[/E2], does not interact with TIMP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gelatinase B", "entity_2_idx": [[126, 138]], "entity_2_idx_in_text_with_entity_marker": [139, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p2", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of [E1]MMP-1[/E1], in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with [E2]TIMP-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p3", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of [E1]gelatinase A[/E1] and [E2]gelatinase B[/E2], does not interact with TIMP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatinase A", "entity_1_idx": [[109, 121]], "entity_1_idx_in_text_with_entity_marker": [113, 125], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gelatinase B", "entity_2_idx": [[126, 138]], "entity_2_idx_in_text_with_entity_marker": [139, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p4", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of [E1]gelatinase A[/E1] and gelatinase B, does not interact with [E2]TIMP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelatinase A", "entity_1_idx": [[109, 121]], "entity_1_idx_in_text_with_entity_marker": [113, 125], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1764_AIMed.d204.s1764.p5", "text": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and gelatinase B, does not interact with TIMP-1.", "text_with_entity_marker": "This demonstrates that the C-terminal hemopexin domain of MMP-1, in contrast to the corresponding regions of gelatinase A and [E1]gelatinase B[/E1], does not interact with [E2]TIMP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelatinase B", "entity_1_idx": [[126, 138]], "entity_1_idx_in_text_with_entity_marker": [130, 142], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[163, 169]], "entity_2_idx_in_text_with_entity_marker": [176, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1765_AIMed.d204.s1765.p0", "text": "In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.", "text_with_entity_marker": "In summary, we have shown that the integrity of the catalytic domain of [E1]MMP-1[/E1] and its ability to bind Zn2+ is absolutely required for complex formation with [E2]TIMP-1[/E2], which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MMP-1", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TIMP-1", "entity_2_idx": [[157, 163]], "entity_2_idx_in_text_with_entity_marker": [170, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1765_AIMed.d204.s1765.p1", "text": "In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.", "text_with_entity_marker": "In summary, we have shown that the integrity of the catalytic domain of [E1]MMP-1[/E1] and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of [E2]MMP-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MMP-1", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[267, 272]], "entity_2_idx_in_text_with_entity_marker": [280, 285], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d204.s1765_AIMed.d204.s1765.p2", "text": "In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with TIMP-1, which further underlines the importance of this region for proper regulation of enzymatic activity of MMP-1.", "text_with_entity_marker": "In summary, we have shown that the integrity of the catalytic domain of MMP-1 and its ability to bind Zn2+ is absolutely required for complex formation with [E1]TIMP-1[/E1], which further underlines the importance of this region for proper regulation of enzymatic activity of [E2]MMP-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIMP-1", "entity_1_idx": [[157, 163]], "entity_1_idx_in_text_with_entity_marker": [161, 167], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP-1", "entity_2_idx": [[267, 272]], "entity_2_idx_in_text_with_entity_marker": [280, 285], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1623_AIMed.d191.s1623.p0", "text": "We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of CD4 and gp120 binding.", "text_with_entity_marker": "We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of [E1]CD4[/E1] and [E2]gp120[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD4", "entity_1_idx": [[137, 140]], "entity_1_idx_in_text_with_entity_marker": [141, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp120", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p0", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "[E1]RANTES[/E1] interacts with [E2]CCR5[/E2] and SDF-1 with CXCR4 receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RANTES", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR5", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p1", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "[E1]RANTES[/E1] interacts with CCR5 and [E2]SDF-1[/E2] with CXCR4 receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RANTES", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SDF-1", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p2", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "[E1]RANTES[/E1] interacts with CCR5 and SDF-1 with [E2]CXCR4[/E2] receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RANTES", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR4", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p3", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "RANTES interacts with [E1]CCR5[/E1] and [E2]SDF-1[/E2] with CXCR4 receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCR5", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SDF-1", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p4", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "RANTES interacts with [E1]CCR5[/E1] and SDF-1 with [E2]CXCR4[/E2] receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCR5", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR4", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p5", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "RANTES interacts with CCR5 and [E1]SDF-1[/E1] with [E2]CXCR4[/E2] receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SDF-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR4", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1633_AIMed.d191.s1633.p0", "text": "DCs express more CCR5 and CXCR4 mRNA than T cells.", "text_with_entity_marker": "DCs express more [E1]CCR5[/E1] and [E2]CXCR4[/E2] mRNA than T cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CCR5", "entity_1_idx": [[17, 21]], "entity_1_idx_in_text_with_entity_marker": [21, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR4", "entity_2_idx": [[26, 31]], "entity_2_idx_in_text_with_entity_marker": [39, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1899_AIMed.d219.s1899.p0", "text": "14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain.", "text_with_entity_marker": "[E1]14-3-3 zeta[/E1] negatively regulates [E2]raf-1[/E2] activity by interactions with the Raf-1 cysteine-rich domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "14-3-3 zeta", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "raf-1", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1899_AIMed.d219.s1899.p1", "text": "14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain.", "text_with_entity_marker": "[E1]14-3-3 zeta[/E1] negatively regulates raf-1 activity by interactions with the [E2]Raf-1[/E2] cysteine-rich domain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "14-3-3 zeta", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1899_AIMed.d219.s1899.p2", "text": "14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain.", "text_with_entity_marker": "14-3-3 zeta negatively regulates [E1]raf-1[/E1] activity by interactions with the [E2]Raf-1[/E2] cysteine-rich domain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "raf-1", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p0", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although [E1]Raf-1[/E1] is a critical effector of [E2]Ras[/E2] signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[41, 44]], "entity_2_idx_in_text_with_entity_marker": [54, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p1", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although [E1]Raf-1[/E1] is a critical effector of Ras signaling and transformation, the mechanism by which [E2]Ras[/E2] promotes Raf-1 activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p2", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although [E1]Raf-1[/E1] is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes [E2]Raf-1[/E2] activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p3", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although Raf-1 is a critical effector of [E1]Ras[/E1] signaling and transformation, the mechanism by which [E2]Ras[/E2] promotes Raf-1 activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p4", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although Raf-1 is a critical effector of [E1]Ras[/E1] signaling and transformation, the mechanism by which Ras promotes [E2]Raf-1[/E2] activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p5", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which [E1]Ras[/E1] promotes [E2]Raf-1[/E2] activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[98, 101]], "entity_1_idx_in_text_with_entity_marker": [102, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p0", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that [E1]Ras[/E1] interaction with the [E2]Raf-1[/E2] cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p1", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that [E1]Ras[/E1] interaction with the [E2]Raf-1 cysteine-rich domain[/E2] (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1 cysteine-rich domain", "entity_2_idx": [[51, 77]], "entity_2_idx_in_text_with_entity_marker": [64, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p2", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that [E1]Ras[/E1] interaction with the Raf-1 cysteine-rich domain ([E2]Raf-CRD[/E2], residues 139-184) may be required for Raf-1 activation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-CRD", "entity_2_idx": [[79, 86]], "entity_2_idx_in_text_with_entity_marker": [92, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p3", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that [E1]Ras[/E1] interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for [E2]Raf-1[/E2] activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p4", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that Ras interaction with the [E1-E2]Raf-1[/E1] cysteine-rich domain[/E2] (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1[/E1] cysteine-rich domain", "entity_2_idx": [[51, 77]], "entity_2_idx_in_text_with_entity_marker": [58, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p5", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that Ras interaction with the [E1]Raf-1[/E1] cysteine-rich domain ([E2]Raf-CRD[/E2], residues 139-184) may be required for Raf-1 activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-CRD", "entity_2_idx": [[79, 86]], "entity_2_idx_in_text_with_entity_marker": [92, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p6", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that Ras interaction with the [E1]Raf-1[/E1] cysteine-rich domain (Raf-CRD, residues 139-184) may be required for [E2]Raf-1[/E2] activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p7", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that Ras interaction with the [E1]Raf-1 cysteine-rich domain[/E1] ([E2]Raf-CRD[/E2], residues 139-184) may be required for Raf-1 activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1 cysteine-rich domain", "entity_1_idx": [[51, 77]], "entity_1_idx_in_text_with_entity_marker": [55, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-CRD", "entity_2_idx": [[79, 86]], "entity_2_idx_in_text_with_entity_marker": [92, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p8", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that Ras interaction with the [E1]Raf-1 cysteine-rich domain[/E1] (Raf-CRD, residues 139-184) may be required for [E2]Raf-1[/E2] activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1 cysteine-rich domain", "entity_1_idx": [[51, 77]], "entity_1_idx_in_text_with_entity_marker": [55, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1901_AIMed.d219.s1901.p9", "text": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain (Raf-CRD, residues 139-184) may be required for Raf-1 activation.", "text_with_entity_marker": "We recently reported that Ras interaction with the Raf-1 cysteine-rich domain ([E1]Raf-CRD[/E1], residues 139-184) may be required for [E2]Raf-1[/E2] activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[79, 86]], "entity_1_idx_in_text_with_entity_marker": [83, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[126, 131]], "entity_2_idx_in_text_with_entity_marker": [139, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1902_AIMed.d219.s1902.p0", "text": "The Raf-CRD is located in the NH2-terminal negative regulatory domain of Raf-1 and is highly homologous to cysteine-rich domains found in protein kinase C family members.", "text_with_entity_marker": "The [E1]Raf-CRD[/E1] is located in the NH2-terminal negative regulatory domain of [E2]Raf-1[/E2] and is highly homologous to cysteine-rich domains found in protein kinase C family members.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1903_AIMed.d219.s1903.p0", "text": "Recent studies indicate that the structural integrity of the Raf-CRD is also critical for Raf-1 interaction with 14-3-3 proteins.", "text_with_entity_marker": "Recent studies indicate that the structural integrity of the [E1]Raf-CRD[/E1] is also critical for [E2]Raf-1[/E2] interaction with 14-3-3 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[61, 68]], "entity_1_idx_in_text_with_entity_marker": [65, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1904_AIMed.d219.s1904.p0", "text": "However, whether 14-3-3 proteins interact directly with the Raf-CRD and how this interaction may mediate Raf-1 function has not been determined.", "text_with_entity_marker": "However, whether 14-3-3 proteins interact directly with the [E1]Raf-CRD[/E1] and how this interaction may mediate [E2]Raf-1[/E2] function has not been determined.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[60, 67]], "entity_1_idx_in_text_with_entity_marker": [64, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1905_AIMed.d219.s1905.p0", "text": "In the present study, we demonstrate that 14-3-3 zeta binds directly to the isolated Raf-CRD.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]14-3-3 zeta[/E1] binds directly to the isolated [E2]Raf-CRD[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "14-3-3 zeta", "entity_1_idx": [[42, 53]], "entity_1_idx_in_text_with_entity_marker": [46, 57], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-CRD", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1906_AIMed.d219.s1906.p0", "text": "Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not Ras, to the Raf-CRD.", "text_with_entity_marker": "Moreover, mutation of [E1]Raf-1[/E1] residues 143-145 impairs binding of 14-3-3, but not [E2]Ras[/E2], to the Raf-CRD.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Raf-1", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[80, 83]], "entity_2_idx_in_text_with_entity_marker": [93, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1906_AIMed.d219.s1906.p1", "text": "Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not Ras, to the Raf-CRD.", "text_with_entity_marker": "Moreover, mutation of [E1]Raf-1[/E1] residues 143-145 impairs binding of 14-3-3, but not Ras, to the [E2]Raf-CRD[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Raf-1", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-CRD", "entity_2_idx": [[92, 99]], "entity_2_idx_in_text_with_entity_marker": [105, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1906_AIMed.d219.s1906.p2", "text": "Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not Ras, to the Raf-CRD.", "text_with_entity_marker": "Moreover, mutation of Raf-1 residues 143-145 impairs binding of 14-3-3, but not [E1]Ras[/E1], to the [E2]Raf-CRD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-CRD", "entity_2_idx": [[92, 99]], "entity_2_idx_in_text_with_entity_marker": [105, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1908_AIMed.d219.s1908.p0", "text": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "text_with_entity_marker": "Thus, 14-3-3 interaction with the [E1]Raf-CRD[/E1] may serve in negative regulation of [E2]Raf-1[/E2] function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1908_AIMed.d219.s1908.p1", "text": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "text_with_entity_marker": "Thus, 14-3-3 interaction with the [E1]Raf-CRD[/E1] may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of [E2]Raf-1[/E2] to promote subsequent events necessary for full activation of Raf-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1908_AIMed.d219.s1908.p2", "text": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "text_with_entity_marker": "Thus, 14-3-3 interaction with the [E1]Raf-CRD[/E1] may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of [E2]Raf-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-CRD", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1908_AIMed.d219.s1908.p3", "text": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "text_with_entity_marker": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of [E1]Raf-1[/E1] function by facilitating dissociation of 14-3-3 from the NH2 terminus of [E2]Raf-1[/E2] to promote subsequent events necessary for full activation of Raf-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1908_AIMed.d219.s1908.p4", "text": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "text_with_entity_marker": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of [E1]Raf-1[/E1] function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of [E2]Raf-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1908_AIMed.d219.s1908.p5", "text": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of Raf-1 to promote subsequent events necessary for full activation of Raf-1.", "text_with_entity_marker": "Thus, 14-3-3 interaction with the Raf-CRD may serve in negative regulation of Raf-1 function by facilitating dissociation of 14-3-3 from the NH2 terminus of [E1]Raf-1[/E1] to promote subsequent events necessary for full activation of [E2]Raf-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Raf-1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1273_AIMed.d150.s1273.p0", "text": "Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.", "text_with_entity_marker": "Regulation of the [E1]Ets[/E1]-related transcription factor [E2]Elf-1[/E2] by binding to the retinoblastoma protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ets", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1273_AIMed.d150.s1273.p1", "text": "Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.", "text_with_entity_marker": "Regulation of the [E1]Ets[/E1]-related transcription factor Elf-1 by binding to the [E2]retinoblastoma[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ets", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "retinoblastoma", "entity_2_idx": [[75, 89]], "entity_2_idx_in_text_with_entity_marker": [88, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1273_AIMed.d150.s1273.p2", "text": "Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.", "text_with_entity_marker": "Regulation of the Ets-related transcription factor [E1]Elf-1[/E1] by binding to the [E2]retinoblastoma[/E2] protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Elf-1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "retinoblastoma", "entity_2_idx": [[75, 89]], "entity_2_idx_in_text_with_entity_marker": [88, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1274_AIMed.d150.s1274.p0", "text": "The retinoblastoma gene product (Rb) is a nuclear phosphoprotein that regulates cell cycle progression.", "text_with_entity_marker": "The [E1]retinoblastoma[/E1] gene product ([E2]Rb[/E2]) is a nuclear phosphoprotein that regulates cell cycle progression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "retinoblastoma", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[33, 35]], "entity_2_idx_in_text_with_entity_marker": [46, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1275_AIMed.d150.s1275.p0", "text": "Elf-1 is a lymphoid-specific Ets transcription factor that regulates inducible gene expression during T cell activation.", "text_with_entity_marker": "[E1]Elf-1[/E1] is a lymphoid-specific [E2]Ets[/E2] transcription factor that regulates inducible gene expression during T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Elf-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ets", "entity_2_idx": [[29, 32]], "entity_2_idx_in_text_with_entity_marker": [42, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1276_AIMed.d150.s1276.p0", "text": "In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.", "text_with_entity_marker": "In this report, it is demonstrated that [E1]Elf-1[/E1] contains a sequence motif that is highly related to the [E2]Rb[/E2] binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Elf-1", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[102, 104]], "entity_2_idx_in_text_with_entity_marker": [115, 117], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1276_AIMed.d150.s1276.p1", "text": "In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.", "text_with_entity_marker": "In this report, it is demonstrated that [E1]Elf-1[/E1] contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of [E2]Rb[/E2] both in vitro and in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Elf-1", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[183, 185]], "entity_2_idx_in_text_with_entity_marker": [196, 198], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1276_AIMed.d150.s1276.p2", "text": "In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo.", "text_with_entity_marker": "In this report, it is demonstrated that Elf-1 contains a sequence motif that is highly related to the [E1]Rb[/E1] binding sites of several viral oncoproteins and binds to the pocket region of [E2]Rb[/E2] both in vitro and in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[102, 104]], "entity_1_idx_in_text_with_entity_marker": [106, 108], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[183, 185]], "entity_2_idx_in_text_with_entity_marker": [196, 198], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1277_AIMed.d150.s1277.p0", "text": "Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.", "text_with_entity_marker": "[E1]Elf-1[/E1] binds exclusively to the underphosphorylated form of [E2]Rb[/E2] and fails to bind to Rb mutants derived from patients with retinoblastoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Elf-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[59, 61]], "entity_2_idx_in_text_with_entity_marker": [72, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1277_AIMed.d150.s1277.p1", "text": "Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.", "text_with_entity_marker": "[E1]Elf-1[/E1] binds exclusively to the underphosphorylated form of Rb and fails to bind to [E2]Rb[/E2] mutants derived from patients with retinoblastoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Elf-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[83, 85]], "entity_2_idx_in_text_with_entity_marker": [96, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1277_AIMed.d150.s1277.p2", "text": "Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.", "text_with_entity_marker": "Elf-1 binds exclusively to the underphosphorylated form of [E1]Rb[/E1] and fails to bind to [E2]Rb[/E2] mutants derived from patients with retinoblastoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[59, 61]], "entity_1_idx_in_text_with_entity_marker": [63, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[83, 85]], "entity_2_idx_in_text_with_entity_marker": [96, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1278_AIMed.d150.s1278.p0", "text": "Co-immunoprecipitation experiments demonstrated an association between Elf-1 and Rb in resting normal human T cells.", "text_with_entity_marker": "Co-immunoprecipitation experiments demonstrated an association between [E1]Elf-1[/E1] and [E2]Rb[/E2] in resting normal human T cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Elf-1", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[81, 83]], "entity_2_idx_in_text_with_entity_marker": [94, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1279_AIMed.d150.s1279.p0", "text": "After T cell activation, the phosphorylation of Rb results in the release of Elf-1, which is correlated temporally with the activation of Elf-1-mediated transcription.", "text_with_entity_marker": "After T cell activation, the phosphorylation of [E1]Rb[/E1] results in the release of [E2]Elf-1[/E2], which is correlated temporally with the activation of Elf-1-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[48, 50]], "entity_1_idx_in_text_with_entity_marker": [52, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1279_AIMed.d150.s1279.p1", "text": "After T cell activation, the phosphorylation of Rb results in the release of Elf-1, which is correlated temporally with the activation of Elf-1-mediated transcription.", "text_with_entity_marker": "After T cell activation, the phosphorylation of [E1]Rb[/E1] results in the release of Elf-1, which is correlated temporally with the activation of [E2]Elf-1[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[48, 50]], "entity_1_idx_in_text_with_entity_marker": [52, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1279_AIMed.d150.s1279.p2", "text": "After T cell activation, the phosphorylation of Rb results in the release of Elf-1, which is correlated temporally with the activation of Elf-1-mediated transcription.", "text_with_entity_marker": "After T cell activation, the phosphorylation of Rb results in the release of [E1]Elf-1[/E1], which is correlated temporally with the activation of [E2]Elf-1[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Elf-1", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1280_AIMed.d150.s1280.p0", "text": "Overexpression of a phosphorylation-defective form of Rb inhibited Elf-1-dependent transcription during T cell activation.", "text_with_entity_marker": "Overexpression of a phosphorylation-defective form of [E1]Rb[/E1] inhibited [E2]Elf-1[/E2]-dependent transcription during T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[54, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1281_AIMed.d150.s1281.p0", "text": "These results demonstrate that Rb interacts specifically with a lineage-restricted Ets transcription factor.", "text_with_entity_marker": "These results demonstrate that [E1]Rb[/E1] interacts specifically with a lineage-restricted [E2]Ets[/E2] transcription factor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[31, 33]], "entity_1_idx_in_text_with_entity_marker": [35, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ets", "entity_2_idx": [[83, 86]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s301_AIMed.d36.s301.p0", "text": "Molecular determinants of the interaction between the C-terminal domain of Alzheimer's beta-amyloid peptide and apolipoprotein E alpha-helices.", "text_with_entity_marker": "Molecular determinants of the interaction between the C-terminal domain of Alzheimer's [E1]beta-amyloid peptide[/E1] and [E2]apolipoprotein E[/E2] alpha-helices.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-amyloid peptide", "entity_1_idx": [[87, 107]], "entity_1_idx_in_text_with_entity_marker": [91, 111], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "apolipoprotein E", "entity_2_idx": [[112, 128]], "entity_2_idx_in_text_with_entity_marker": [125, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s302_AIMed.d36.s302.p0", "text": "In a previous work, we predicted and demonstrated that the 29-42-residue fragment of beta-amyloid peptide (Abeta peptide) has in vitro capacities close to those of the tilted fragment of viral fusion proteins.", "text_with_entity_marker": "In a previous work, we predicted and demonstrated that the 29-42-residue fragment of [E1]beta-amyloid peptide[/E1] ([E2]Abeta peptide[/E2]) has in vitro capacities close to those of the tilted fragment of viral fusion proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-amyloid peptide", "entity_1_idx": [[85, 105]], "entity_1_idx_in_text_with_entity_marker": [89, 109], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta peptide", "entity_2_idx": [[107, 120]], "entity_2_idx_in_text_with_entity_marker": [120, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s303_AIMed.d36.s303.p0", "text": "We further demonstrated that apolipoprotein E2 and E3 but not apolipoprotein E4 can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.", "text_with_entity_marker": "We further demonstrated that [E1]apolipoprotein E2[/E1] and E3 but not [E2]apolipoprotein E4[/E2] can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "apolipoprotein E2", "entity_1_idx": [[29, 46]], "entity_1_idx_in_text_with_entity_marker": [33, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "apolipoprotein E4", "entity_2_idx": [[62, 79]], "entity_2_idx_in_text_with_entity_marker": [75, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s303_AIMed.d36.s303.p1", "text": "We further demonstrated that apolipoprotein E2 and E3 but not apolipoprotein E4 can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.", "text_with_entity_marker": "We further demonstrated that [E1]apolipoprotein E2[/E1] and E3 but not apolipoprotein E4 can decrease the fusogenic activity of [E2]Abeta[/E2](29-42) via a direct interaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "apolipoprotein E2", "entity_1_idx": [[29, 46]], "entity_1_idx_in_text_with_entity_marker": [33, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s303_AIMed.d36.s303.p2", "text": "We further demonstrated that apolipoprotein E2 and E3 but not apolipoprotein E4 can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.", "text_with_entity_marker": "We further demonstrated that apolipoprotein E2 and E3 but not [E1]apolipoprotein E4[/E1] can decrease the fusogenic activity of [E2]Abeta[/E2](29-42) via a direct interaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "apolipoprotein E4", "entity_1_idx": [[62, 79]], "entity_1_idx_in_text_with_entity_marker": [66, 83], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s304_AIMed.d36.s304.p0", "text": "Therefore, we suggested that this fragment is implicated in the neurotoxicity of Abeta and in the protective effects of apolipoprotein E in Alzheimer's disease.", "text_with_entity_marker": "Therefore, we suggested that this fragment is implicated in the neurotoxicity of [E1]Abeta[/E1] and in the protective effects of [E2]apolipoprotein E[/E2] in Alzheimer's disease.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abeta", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "apolipoprotein E", "entity_2_idx": [[120, 136]], "entity_2_idx_in_text_with_entity_marker": [133, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s306_AIMed.d36.s306.p0", "text": "In this study, we simulated interactions of all amphipathic helices of apolipoproteins E and A-I with Abeta and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.", "text_with_entity_marker": "In this study, we simulated interactions of all amphipathic helices of [E1]apolipoproteins E[/E1] and A-I with [E2]Abeta[/E2] and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "apolipoproteins E", "entity_1_idx": [[71, 88]], "entity_1_idx_in_text_with_entity_marker": [75, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s838_AIMed.d99.s838.p0", "text": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.", "text_with_entity_marker": "The cloned [E1]CSB[/E1] gene encodes a member of a protein family that includes the yeast [E2]Snf2[/E2] protein, a component of the transcriptional regulator Swi/Snf.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CSB", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Snf2", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s838_AIMed.d99.s838.p1", "text": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.", "text_with_entity_marker": "The cloned [E1]CSB[/E1] gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator [E2]Swi[/E2]/Snf.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CSB", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Swi", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s838_AIMed.d99.s838.p2", "text": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.", "text_with_entity_marker": "The cloned [E1]CSB[/E1] gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/[E2]Snf[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CSB", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Snf", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s838_AIMed.d99.s838.p3", "text": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.", "text_with_entity_marker": "The cloned CSB gene encodes a member of a protein family that includes the yeast [E1]Snf2[/E1] protein, a component of the transcriptional regulator [E2]Swi[/E2]/Snf.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Snf2", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Swi", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s838_AIMed.d99.s838.p4", "text": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.", "text_with_entity_marker": "The cloned CSB gene encodes a member of a protein family that includes the yeast [E1]Snf2[/E1] protein, a component of the transcriptional regulator Swi/[E2]Snf[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Snf2", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Snf", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s838_AIMed.d99.s838.p5", "text": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator Swi/Snf.", "text_with_entity_marker": "The cloned CSB gene encodes a member of a protein family that includes the yeast Snf2 protein, a component of the transcriptional regulator [E1]Swi[/E1]/[E2]Snf[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Swi", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Snf", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s841_AIMed.d99.s841.p0", "text": "CSA protein interacts with CSB protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "text_with_entity_marker": "[E1]CSA[/E1] protein interacts with [E2]CSB[/E2] protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CSA", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CSB", "entity_2_idx": [[27, 30]], "entity_2_idx_in_text_with_entity_marker": [40, 43], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s841_AIMed.d99.s841.p1", "text": "CSA protein interacts with CSB protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "text_with_entity_marker": "[E1]CSA[/E1] protein interacts with CSB protein and with [E2]p44[/E2] protein, a subunit of the human RNA polymerase II transcription factor IIH.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CSA", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p44", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s841_AIMed.d99.s841.p2", "text": "CSA protein interacts with CSB protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "text_with_entity_marker": "CSA protein interacts with [E1]CSB[/E1] protein and with [E2]p44[/E2] protein, a subunit of the human RNA polymerase II transcription factor IIH.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CSB", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p44", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s842_AIMed.d99.s842.p0", "text": "These observations suggest that the products of the CSA and CSB genes are involved in transcription.", "text_with_entity_marker": "These observations suggest that the products of the [E1]CSA[/E1] and [E2]CSB[/E2] genes are involved in transcription.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CSA", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CSB", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p0", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of [E1]p60[/E1], a mediator of [E2]progesterone receptor[/E2] assembly, with heat shock proteins hsp90 and hsp70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "progesterone receptor", "entity_2_idx": [[35, 56]], "entity_2_idx_in_text_with_entity_marker": [48, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p1", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of [E1]p60[/E1], a mediator of progesterone receptor assembly, with heat shock proteins [E2]hsp90[/E2] and hsp70.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p2", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of [E1]p60[/E1], a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and [E2]hsp70[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p3", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of p60, a mediator of [E1]progesterone receptor[/E1] assembly, with heat shock proteins [E2]hsp90[/E2] and hsp70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "progesterone receptor", "entity_1_idx": [[35, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p4", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of p60, a mediator of [E1]progesterone receptor[/E1] assembly, with heat shock proteins hsp90 and [E2]hsp70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "progesterone receptor", "entity_1_idx": [[35, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1483_AIMed.d176.s1483.p5", "text": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70.", "text_with_entity_marker": "Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins [E1]hsp90[/E1] and [E2]hsp70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1484_AIMed.d176.s1484.p0", "text": "Previous studies on the assembly of progesterone receptor (PR) complexes in vitro have suggested that PR assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.", "text_with_entity_marker": "Previous studies on the assembly of [E1]progesterone receptor[/E1] ([E2]PR[/E2]) complexes in vitro have suggested that PR assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "progesterone receptor", "entity_1_idx": [[36, 57]], "entity_1_idx_in_text_with_entity_marker": [40, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[59, 61]], "entity_2_idx_in_text_with_entity_marker": [72, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1484_AIMed.d176.s1484.p1", "text": "Previous studies on the assembly of progesterone receptor (PR) complexes in vitro have suggested that PR assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.", "text_with_entity_marker": "Previous studies on the assembly of [E1]progesterone receptor[/E1] (PR) complexes in vitro have suggested that [E2]PR[/E2] assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "progesterone receptor", "entity_1_idx": [[36, 57]], "entity_1_idx_in_text_with_entity_marker": [40, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[102, 104]], "entity_2_idx_in_text_with_entity_marker": [115, 117], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1484_AIMed.d176.s1484.p2", "text": "Previous studies on the assembly of progesterone receptor (PR) complexes in vitro have suggested that PR assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.", "text_with_entity_marker": "Previous studies on the assembly of progesterone receptor ([E1]PR[/E1]) complexes in vitro have suggested that [E2]PR[/E2] assembly is a dynamic, ordered process involving at least eight nonreceptor proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[59, 61]], "entity_1_idx_in_text_with_entity_marker": [63, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[102, 104]], "entity_2_idx_in_text_with_entity_marker": [115, 117], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1485_AIMed.d176.s1485.p0", "text": "One of these proteins, p60, appears transiently during assembly and is not a component of functionally mature PR complexes.", "text_with_entity_marker": "One of these proteins, [E1]p60[/E1], appears transiently during assembly and is not a component of functionally mature [E2]PR[/E2] complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[110, 112]], "entity_2_idx_in_text_with_entity_marker": [123, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p0", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature [E2]PR[/E2] complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[126, 128]], "entity_2_idx_in_text_with_entity_marker": [139, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p1", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing [E2]heat shock protein 90[/E2] (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "heat shock protein 90", "entity_2_idx": [[150, 171]], "entity_2_idx_in_text_with_entity_marker": [163, 184], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p2", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ([E2]hsp90[/E2]), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p3", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), [E2]p23[/E2], and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p4", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early [E2]PR[/E2] complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[249, 251]], "entity_2_idx_in_text_with_entity_marker": [262, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p5", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing [E2]hsp70[/E2] and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[273, 278]], "entity_2_idx_in_text_with_entity_marker": [286, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p6", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p7", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for [E1]p60[/E1] can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p8", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing [E2]heat shock protein 90[/E2] (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "heat shock protein 90", "entity_2_idx": [[150, 171]], "entity_2_idx_in_text_with_entity_marker": [163, 184], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p9", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing heat shock protein 90 ([E2]hsp90[/E2]), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p10", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing heat shock protein 90 (hsp90), [E2]p23[/E2], and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p11", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early [E2]PR[/E2] complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[249, 251]], "entity_2_idx_in_text_with_entity_marker": [262, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p12", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing [E2]hsp70[/E2] and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[273, 278]], "entity_2_idx_in_text_with_entity_marker": [286, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p13", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p14", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature [E1]PR[/E1] complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[126, 128]], "entity_1_idx_in_text_with_entity_marker": [130, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p15", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing [E1]heat shock protein 90[/E1] ([E2]hsp90[/E2]), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "heat shock protein 90", "entity_1_idx": [[150, 171]], "entity_1_idx_in_text_with_entity_marker": [154, 175], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p16", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing [E1]heat shock protein 90[/E1] (hsp90), [E2]p23[/E2], and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "heat shock protein 90", "entity_1_idx": [[150, 171]], "entity_1_idx_in_text_with_entity_marker": [154, 175], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p17", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing [E1]heat shock protein 90[/E1] (hsp90), p23, and immunophilins and, on the other, enhance recovery of early [E2]PR[/E2] complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "heat shock protein 90", "entity_1_idx": [[150, 171]], "entity_1_idx_in_text_with_entity_marker": [154, 175], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[249, 251]], "entity_2_idx_in_text_with_entity_marker": [262, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p18", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing [E1]heat shock protein 90[/E1] (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing [E2]hsp70[/E2] and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "heat shock protein 90", "entity_1_idx": [[150, 171]], "entity_1_idx_in_text_with_entity_marker": [154, 175], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[273, 278]], "entity_2_idx_in_text_with_entity_marker": [286, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p19", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing [E1]heat shock protein 90[/E1] (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "heat shock protein 90", "entity_1_idx": [[150, 171]], "entity_1_idx_in_text_with_entity_marker": [154, 175], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p20", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing [E1]heat shock protein 90[/E1] (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "heat shock protein 90", "entity_1_idx": [[150, 171]], "entity_1_idx_in_text_with_entity_marker": [154, 175], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p21", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ([E1]hsp90[/E1]), [E2]p23[/E2], and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p22", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ([E1]hsp90[/E1]), p23, and immunophilins and, on the other, enhance recovery of early [E2]PR[/E2] complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[249, 251]], "entity_2_idx_in_text_with_entity_marker": [262, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p23", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ([E1]hsp90[/E1]), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing [E2]hsp70[/E2] and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[273, 278]], "entity_2_idx_in_text_with_entity_marker": [286, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p24", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ([E1]hsp90[/E1]), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p25", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 ([E1]hsp90[/E1]), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p26", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), [E1]p23[/E1], and immunophilins and, on the other, enhance recovery of early [E2]PR[/E2] complexes containing hsp70 and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p23", "entity_1_idx": [[181, 184]], "entity_1_idx_in_text_with_entity_marker": [185, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[249, 251]], "entity_2_idx_in_text_with_entity_marker": [262, 264], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p27", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), [E1]p23[/E1], and immunophilins and, on the other, enhance recovery of early PR complexes containing [E2]hsp70[/E2] and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p23", "entity_1_idx": [[181, 184]], "entity_1_idx_in_text_with_entity_marker": [185, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[273, 278]], "entity_2_idx_in_text_with_entity_marker": [286, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p28", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), [E1]p23[/E1], and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p23", "entity_1_idx": [[181, 184]], "entity_1_idx_in_text_with_entity_marker": [185, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p29", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), [E1]p23[/E1], and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p23", "entity_1_idx": [[181, 184]], "entity_1_idx_in_text_with_entity_marker": [185, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p30", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early [E1]PR[/E1] complexes containing [E2]hsp70[/E2] and Hip (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[249, 251]], "entity_1_idx_in_text_with_entity_marker": [253, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[273, 278]], "entity_2_idx_in_text_with_entity_marker": [286, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p31", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early [E1]PR[/E1] complexes containing hsp70 and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[249, 251]], "entity_1_idx_in_text_with_entity_marker": [253, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p32", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early [E1]PR[/E1] complexes containing hsp70 and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[249, 251]], "entity_1_idx_in_text_with_entity_marker": [253, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p33", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing [E1]hsp70[/E1] and [E2]Hip[/E2] (p48).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[273, 278]], "entity_1_idx_in_text_with_entity_marker": [277, 282], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Hip", "entity_2_idx": [[283, 286]], "entity_2_idx_in_text_with_entity_marker": [296, 299], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p34", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing [E1]hsp70[/E1] and Hip ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[273, 278]], "entity_1_idx_in_text_with_entity_marker": [277, 282], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1486_AIMed.d176.s1486.p35", "text": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).", "text_with_entity_marker": "In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and [E1]Hip[/E1] ([E2]p48[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Hip", "entity_1_idx": [[283, 286]], "entity_1_idx_in_text_with_entity_marker": [287, 290], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p48", "entity_2_idx": [[288, 291]], "entity_2_idx_in_text_with_entity_marker": [301, 304], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1487_AIMed.d176.s1487.p0", "text": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.", "text_with_entity_marker": "This observation supports a model in which [E1]p60[/E1] functions at an intermediate stage of [E2]PR[/E2] assembly to facilitate formation of subsequent PR complexes lacking p60.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[85, 87]], "entity_2_idx_in_text_with_entity_marker": [98, 100], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1487_AIMed.d176.s1487.p1", "text": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.", "text_with_entity_marker": "This observation supports a model in which [E1]p60[/E1] functions at an intermediate stage of PR assembly to facilitate formation of subsequent [E2]PR[/E2] complexes lacking p60.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[135, 137]], "entity_2_idx_in_text_with_entity_marker": [148, 150], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1487_AIMed.d176.s1487.p2", "text": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.", "text_with_entity_marker": "This observation supports a model in which [E1]p60[/E1] functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking [E2]p60[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1487_AIMed.d176.s1487.p3", "text": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.", "text_with_entity_marker": "This observation supports a model in which p60 functions at an intermediate stage of [E1]PR[/E1] assembly to facilitate formation of subsequent [E2]PR[/E2] complexes lacking p60.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[85, 87]], "entity_1_idx_in_text_with_entity_marker": [89, 91], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[135, 137]], "entity_2_idx_in_text_with_entity_marker": [148, 150], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1487_AIMed.d176.s1487.p4", "text": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.", "text_with_entity_marker": "This observation supports a model in which p60 functions at an intermediate stage of [E1]PR[/E1] assembly to facilitate formation of subsequent PR complexes lacking [E2]p60[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[85, 87]], "entity_1_idx_in_text_with_entity_marker": [89, 91], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1487_AIMed.d176.s1487.p5", "text": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent PR complexes lacking p60.", "text_with_entity_marker": "This observation supports a model in which p60 functions at an intermediate stage of PR assembly to facilitate formation of subsequent [E1]PR[/E1] complexes lacking [E2]p60[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[135, 137]], "entity_1_idx_in_text_with_entity_marker": [139, 141], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1488_AIMed.d176.s1488.p0", "text": "Since p60 is typically found in a complex with hsp90 and hsp70, we have further characterized its interactions with these proteins.", "text_with_entity_marker": "Since [E1]p60[/E1] is typically found in a complex with [E2]hsp90[/E2] and hsp70, we have further characterized its interactions with these proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1488_AIMed.d176.s1488.p1", "text": "Since p60 is typically found in a complex with hsp90 and hsp70, we have further characterized its interactions with these proteins.", "text_with_entity_marker": "Since [E1]p60[/E1] is typically found in a complex with hsp90 and [E2]hsp70[/E2], we have further characterized its interactions with these proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1488_AIMed.d176.s1488.p2", "text": "Since p60 is typically found in a complex with hsp90 and hsp70, we have further characterized its interactions with these proteins.", "text_with_entity_marker": "Since p60 is typically found in a complex with [E1]hsp90[/E1] and [E2]hsp70[/E2], we have further characterized its interactions with these proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1489_AIMed.d176.s1489.p0", "text": "P60 can bind either hsp70 or hsp90 independently and in an ATP-independent manner.", "text_with_entity_marker": "[E1]P60[/E1] can bind either [E2]hsp70[/E2] or hsp90 independently and in an ATP-independent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P60", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[20, 25]], "entity_2_idx_in_text_with_entity_marker": [33, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1489_AIMed.d176.s1489.p1", "text": "P60 can bind either hsp70 or hsp90 independently and in an ATP-independent manner.", "text_with_entity_marker": "[E1]P60[/E1] can bind either hsp70 or [E2]hsp90[/E2] independently and in an ATP-independent manner.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P60", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[29, 34]], "entity_2_idx_in_text_with_entity_marker": [42, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1489_AIMed.d176.s1489.p2", "text": "P60 can bind either hsp70 or hsp90 independently and in an ATP-independent manner.", "text_with_entity_marker": "P60 can bind either [E1]hsp70[/E1] or [E2]hsp90[/E2] independently and in an ATP-independent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[29, 34]], "entity_2_idx_in_text_with_entity_marker": [42, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p0", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since [E1]hsp90[/E1] and [E2]hsp70[/E2] do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[16, 21]], "entity_2_idx_in_text_with_entity_marker": [29, 34], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p1", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since [E1]hsp90[/E1] and hsp70 do not readily associate on their own, it appears that [E2]p60[/E2] is the central organizing component of an hsp90-p60-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[77, 80]], "entity_2_idx_in_text_with_entity_marker": [90, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p2", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since [E1]hsp90[/E1] and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an [E2]hsp90[/E2]-p60-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p3", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since [E1]hsp90[/E1] and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-[E2]p60[/E2]-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p4", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since [E1]hsp90[/E1] and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-[E2]hsp70[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p5", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and [E1]hsp70[/E1] do not readily associate on their own, it appears that [E2]p60[/E2] is the central organizing component of an hsp90-p60-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[77, 80]], "entity_2_idx_in_text_with_entity_marker": [90, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p6", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and [E1]hsp70[/E1] do not readily associate on their own, it appears that p60 is the central organizing component of an [E2]hsp90[/E2]-p60-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p7", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and [E1]hsp70[/E1] do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-[E2]p60[/E2]-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p8", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and [E1]hsp70[/E1] do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-[E2]hsp70[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p9", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that [E1]p60[/E1] is the central organizing component of an [E2]hsp90[/E2]-p60-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p10", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that [E1]p60[/E1] is the central organizing component of an hsp90-[E2]p60[/E2]-hsp70 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p11", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that [E1]p60[/E1] is the central organizing component of an hsp90-p60-[E2]hsp70[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p12", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an [E1]hsp90[/E1]-[E2]p60[/E2]-hsp70 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hsp90", "entity_1_idx": [[123, 128]], "entity_1_idx_in_text_with_entity_marker": [127, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[129, 132]], "entity_2_idx_in_text_with_entity_marker": [142, 145], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p13", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an [E1]hsp90[/E1]-p60-[E2]hsp70[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[123, 128]], "entity_1_idx_in_text_with_entity_marker": [127, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1490_AIMed.d176.s1490.p14", "text": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.", "text_with_entity_marker": "Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-[E1]p60[/E1]-[E2]hsp70[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[129, 132]], "entity_1_idx_in_text_with_entity_marker": [133, 136], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p0", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of [E1]p60[/E1] indicates that the N terminus is required for [E2]hsp70[/E2] binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p1", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of [E1]p60[/E1] indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding [E2]hsp90[/E2] and hsp70.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p2", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of [E1]p60[/E1] indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and [E2]hsp70[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p3", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of p60 indicates that the N terminus is required for [E1]hsp70[/E1] binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding [E2]hsp90[/E2] and hsp70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[73, 78]], "entity_1_idx_in_text_with_entity_marker": [77, 82], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p4", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of p60 indicates that the N terminus is required for [E1]hsp70[/E1] binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and [E2]hsp70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[73, 78]], "entity_1_idx_in_text_with_entity_marker": [77, 82], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1491_AIMed.d176.s1491.p5", "text": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding hsp90 and hsp70.", "text_with_entity_marker": "Mutational analysis of p60 indicates that the N terminus is required for hsp70 binding, and a central region containing tetratricopeptide repeat motifs is necessary for binding [E1]hsp90[/E1] and [E2]hsp70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[177, 182]], "entity_1_idx_in_text_with_entity_marker": [181, 186], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p0", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The [E1]hsp90[/E1]-[E2]p60[/E2]-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hsp90", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p60", "entity_2_idx": [[10, 13]], "entity_2_idx_in_text_with_entity_marker": [23, 26], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p1", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The [E1]hsp90[/E1]-p60-[E2]hsp70[/E2] multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p2", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The [E1]hsp90[/E1]-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the [E2]hsp90[/E2]-binding drug geldanamycin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p3", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The hsp90-[E1]p60[/E1]-[E2]hsp70[/E2] multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p4", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The hsp90-[E1]p60[/E1]-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the [E2]hsp90[/E2]-binding drug geldanamycin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1492_AIMed.d176.s1492.p5", "text": "The hsp90-p60-hsp70 multichaperone complex is highly dynamic and does not appear to be affected by the hsp90-binding drug geldanamycin.", "text_with_entity_marker": "The hsp90-p60-[E1]hsp70[/E1] multichaperone complex is highly dynamic and does not appear to be affected by the [E2]hsp90[/E2]-binding drug geldanamycin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p0", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of [E1]hsp70[/E1] and [E2]hsp90[/E2] in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[30, 35]], "entity_2_idx_in_text_with_entity_marker": [43, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p1", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of [E1]hsp70[/E1] and hsp90 in intermediate [E2]PR[/E2] complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[52, 54]], "entity_2_idx_in_text_with_entity_marker": [65, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p2", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of [E1]hsp70[/E1] and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early [E2]PR[/E2] complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p3", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of [E1]hsp70[/E1] and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ([E2]hsp70[/E2]) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[146, 151]], "entity_2_idx_in_text_with_entity_marker": [159, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p4", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of [E1]hsp70[/E1] and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature [E2]PR[/E2] complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[166, 168]], "entity_2_idx_in_text_with_entity_marker": [179, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p5", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and [E1]hsp90[/E1] in intermediate [E2]PR[/E2] complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[52, 54]], "entity_2_idx_in_text_with_entity_marker": [65, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p6", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and [E1]hsp90[/E1] in intermediate PR complexes are shown to be distinct from their separate interactions in early [E2]PR[/E2] complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p7", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and [E1]hsp90[/E1] in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ([E2]hsp70[/E2]) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[146, 151]], "entity_2_idx_in_text_with_entity_marker": [159, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p8", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and [E1]hsp90[/E1] in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature [E2]PR[/E2] complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp90", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[166, 168]], "entity_2_idx_in_text_with_entity_marker": [179, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p9", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and hsp90 in intermediate [E1]PR[/E1] complexes are shown to be distinct from their separate interactions in early [E2]PR[/E2] complexes (hsp70) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p10", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and hsp90 in intermediate [E1]PR[/E1] complexes are shown to be distinct from their separate interactions in early PR complexes ([E2]hsp70[/E2]) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[146, 151]], "entity_2_idx_in_text_with_entity_marker": [159, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p11", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and hsp90 in intermediate [E1]PR[/E1] complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature [E2]PR[/E2] complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[166, 168]], "entity_2_idx_in_text_with_entity_marker": [179, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p12", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early [E1]PR[/E1] complexes ([E2]hsp70[/E2]) or in mature PR complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[132, 134]], "entity_1_idx_in_text_with_entity_marker": [136, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp70", "entity_2_idx": [[146, 151]], "entity_2_idx_in_text_with_entity_marker": [159, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p13", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early [E1]PR[/E1] complexes (hsp70) or in mature [E2]PR[/E2] complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PR", "entity_1_idx": [[132, 134]], "entity_1_idx_in_text_with_entity_marker": [136, 138], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[166, 168]], "entity_2_idx_in_text_with_entity_marker": [179, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1493_AIMed.d176.s1493.p14", "text": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).", "text_with_entity_marker": "The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes ([E1]hsp70[/E1]) or in mature [E2]PR[/E2] complexes (hsp90).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hsp70", "entity_1_idx": [[146, 151]], "entity_1_idx_in_text_with_entity_marker": [150, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[166, 168]], "entity_2_idx_in_text_with_entity_marker": [179, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1494_AIMed.d176.s1494.p0", "text": "From these results, it appears that p60 is a key mediator in the chaperoned assembly and functional maturation of PR complexes.", "text_with_entity_marker": "From these results, it appears that [E1]p60[/E1] is a key mediator in the chaperoned assembly and functional maturation of [E2]PR[/E2] complexes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p60", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[114, 116]], "entity_2_idx_in_text_with_entity_marker": [127, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s586_AIMed.d69.s586.p0", "text": "Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.", "text_with_entity_marker": "Activation of [E1]protein kinase C[/E1] decreases phosphorylation of [E2]c-Jun[/E2] at sites that negatively regulate its DNA-binding activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[14, 30]], "entity_1_idx_in_text_with_entity_marker": [18, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s587_AIMed.d69.s587.p0", "text": "In resting human epithelial and fibroblastic cells, c-Jun is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 (GSK-3).", "text_with_entity_marker": "In resting human epithelial and fibroblastic cells, [E1]c-Jun[/E1] is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by [E2]glycogen synthase kinase 3[/E2] (GSK-3).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Jun", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "glycogen synthase kinase 3", "entity_2_idx": [[161, 187]], "entity_2_idx_in_text_with_entity_marker": [174, 200], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s587_AIMed.d69.s587.p1", "text": "In resting human epithelial and fibroblastic cells, c-Jun is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 (GSK-3).", "text_with_entity_marker": "In resting human epithelial and fibroblastic cells, [E1]c-Jun[/E1] is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 ([E2]GSK-3[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Jun", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GSK-3", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s587_AIMed.d69.s587.p2", "text": "In resting human epithelial and fibroblastic cells, c-Jun is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by glycogen synthase kinase 3 (GSK-3).", "text_with_entity_marker": "In resting human epithelial and fibroblastic cells, c-Jun is phosphorylated on serine and threonine at five sites, three of which are phosphorylated in vitro by [E1]glycogen synthase kinase 3[/E1] ([E2]GSK-3[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycogen synthase kinase 3", "entity_1_idx": [[161, 187]], "entity_1_idx_in_text_with_entity_marker": [165, 191], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GSK-3", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s589_AIMed.d69.s589.p0", "text": "Activation of protein kinase C results in rapid, site-specific dephosphorylation of c-Jun at one or more of these three sites and is coincident with increased AP-1-binding activity.", "text_with_entity_marker": "Activation of [E1]protein kinase C[/E1] results in rapid, site-specific dephosphorylation of [E2]c-Jun[/E2] at one or more of these three sites and is coincident with increased AP-1-binding activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[14, 30]], "entity_1_idx_in_text_with_entity_marker": [18, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s589_AIMed.d69.s589.p1", "text": "Activation of protein kinase C results in rapid, site-specific dephosphorylation of c-Jun at one or more of these three sites and is coincident with increased AP-1-binding activity.", "text_with_entity_marker": "Activation of [E1]protein kinase C[/E1] results in rapid, site-specific dephosphorylation of c-Jun at one or more of these three sites and is coincident with increased [E2]AP-1[/E2]-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase C", "entity_1_idx": [[14, 30]], "entity_1_idx_in_text_with_entity_marker": [18, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s589_AIMed.d69.s589.p2", "text": "Activation of protein kinase C results in rapid, site-specific dephosphorylation of c-Jun at one or more of these three sites and is coincident with increased AP-1-binding activity.", "text_with_entity_marker": "Activation of protein kinase C results in rapid, site-specific dephosphorylation of [E1]c-Jun[/E1] at one or more of these three sites and is coincident with increased [E2]AP-1[/E2]-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-Jun", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s590_AIMed.d69.s590.p0", "text": "Phosphorylation of recombinant human c-Jun proteins in vitro by GSK-3 decreases their DNA-binding activity.", "text_with_entity_marker": "Phosphorylation of recombinant human [E1]c-Jun[/E1] proteins in vitro by [E2]GSK-3[/E2] decreases their DNA-binding activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Jun", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GSK-3", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d69.s592_AIMed.d69.s592.p0", "text": "We propose that c-Jun is present in resting cells in a latent, phosphorylated form that can be activated by site-specific dephosphorylation in response to protein kinase C activation.", "text_with_entity_marker": "We propose that [E1]c-Jun[/E1] is present in resting cells in a latent, phosphorylated form that can be activated by site-specific dephosphorylation in response to [E2]protein kinase C[/E2] activation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Jun", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[155, 171]], "entity_2_idx_in_text_with_entity_marker": [168, 184], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d130.s1112_AIMed.d130.s1112.p0", "text": "Cloning of the complete coding region for human protein phosphatase inhibitor 2 using the two hybrid system and expression of inhibitor 2 in E. coli.", "text_with_entity_marker": "Cloning of the complete coding region for human [E1]protein phosphatase inhibitor 2[/E1] using the two hybrid system and expression of [E2]inhibitor 2[/E2] in E. coli.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein phosphatase inhibitor 2", "entity_1_idx": [[48, 79]], "entity_1_idx_in_text_with_entity_marker": [52, 83], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "inhibitor 2", "entity_2_idx": [[126, 137]], "entity_2_idx_in_text_with_entity_marker": [139, 150], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1165_AIMed.d138.s1165.p0", "text": "Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9.", "text_with_entity_marker": "Interaction of mammalian splicing factor [E1]SF3a[/E1] with [E2]U2 snRNP[/E2] and relation of its 60-kD subunit to yeast PRP9.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SF3a", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[51, 59]], "entity_2_idx_in_text_with_entity_marker": [64, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1165_AIMed.d138.s1165.p1", "text": "Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9.", "text_with_entity_marker": "Interaction of mammalian splicing factor [E1]SF3a[/E1] with U2 snRNP and relation of its 60-kD subunit to yeast [E2]PRP9[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1165_AIMed.d138.s1165.p2", "text": "Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9.", "text_with_entity_marker": "Interaction of mammalian splicing factor SF3a with [E1]U2 snRNP[/E1] and relation of its 60-kD subunit to yeast [E2]PRP9[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[51, 59]], "entity_1_idx_in_text_with_entity_marker": [55, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1166_AIMed.d138.s1166.p0", "text": "In the assembly of a prespliceosome, U2 small nuclear ribonucleoprotein (snRNP) functions in pre-messenger RNA (mRNA) splicing together with splicing factors (SFs) 3a, SF3b, and several other proteins.", "text_with_entity_marker": "In the assembly of a prespliceosome, [E1]U2 small nuclear ribonucleoprotein[/E1] (snRNP) functions in pre-messenger RNA (mRNA) splicing together with splicing factors (SFs) 3a, [E2]SF3b[/E2], and several other proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 small nuclear ribonucleoprotein", "entity_1_idx": [[37, 71]], "entity_1_idx_in_text_with_entity_marker": [41, 75], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1168_AIMed.d138.s1168.p0", "text": "Here it is shown that the SF3a subunits correspond to three of the 17S U2 snRNP-specific polypeptides.", "text_with_entity_marker": "Here it is shown that the [E1]SF3a[/E1] subunits correspond to three of the 17S [E2]U2 snRNP[/E2]-specific polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[71, 79]], "entity_2_idx_in_text_with_entity_marker": [84, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p0", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with [E2]U2 snRNP[/E2] in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[20, 28]], "entity_2_idx_in_text_with_entity_marker": [33, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p1", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with U2 snRNP in the presence of [E2]SF3b[/E2] to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[48, 52]], "entity_2_idx_in_text_with_entity_marker": [61, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p2", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S [E2]U2 snRNP[/E2], which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p3", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for [E2]SF3a[/E2] and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3a", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p4", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and [E2]SF3b[/E2] in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p5", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "[E1]SF3a[/E1] interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of [E2]U2 snRNP[/E2] into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p6", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with [E1]U2 snRNP[/E1] in the presence of [E2]SF3b[/E2] to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[48, 52]], "entity_2_idx_in_text_with_entity_marker": [61, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p7", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with [E1]U2 snRNP[/E1] in the presence of SF3b to generate a structure similar to 17S [E2]U2 snRNP[/E2], which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p8", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with [E1]U2 snRNP[/E1] in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for [E2]SF3a[/E2] and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3a", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p9", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with [E1]U2 snRNP[/E1] in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and [E2]SF3b[/E2] in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p10", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with [E1]U2 snRNP[/E1] in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of [E2]U2 snRNP[/E2] into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p11", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of [E1]SF3b[/E1] to generate a structure similar to 17S [E2]U2 snRNP[/E2], which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3b", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p12", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of [E1]SF3b[/E1] to generate a structure similar to 17S U2 snRNP, which suggests a function for [E2]SF3a[/E2] and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3b", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3a", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p13", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of [E1]SF3b[/E1] to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and [E2]SF3b[/E2] in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3b", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p14", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of [E1]SF3b[/E1] to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of [E2]U2 snRNP[/E2] into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3b", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p15", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S [E1]U2 snRNP[/E1], which suggests a function for [E2]SF3a[/E2] and SF3b in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3a", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p16", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S [E1]U2 snRNP[/E1], which suggests a function for SF3a and [E2]SF3b[/E2] in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p17", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S [E1]U2 snRNP[/E1], which suggests a function for SF3a and SF3b in the incorporation of [E2]U2 snRNP[/E2] into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "U2 snRNP", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p18", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for [E1]SF3a[/E1] and [E2]SF3b[/E2] in the incorporation of U2 snRNP into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[132, 136]], "entity_1_idx_in_text_with_entity_marker": [136, 140], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SF3b", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p19", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for [E1]SF3a[/E1] and SF3b in the incorporation of [E2]U2 snRNP[/E2] into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[132, 136]], "entity_1_idx_in_text_with_entity_marker": [136, 140], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1169_AIMed.d138.s1169.p20", "text": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome.", "text_with_entity_marker": "SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and [E1]SF3b[/E1] in the incorporation of [E2]U2 snRNP[/E2] into the spliceosome.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3b", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1170_AIMed.d138.s1170.p0", "text": "Furthermore, the 60-kilodalton subunit of SF3a is related to the yeast splicing protein PRP9.", "text_with_entity_marker": "Furthermore, the 60-kilodalton subunit of [E1]SF3a[/E1] is related to the yeast splicing protein [E2]PRP9[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[88, 92]], "entity_2_idx_in_text_with_entity_marker": [101, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
